rfhg_58664.1

Basic information about the TSS

---

TSS ID: rfhg_58664.1 Species: human Chr: chr4		Start: 73258576 End: 73258606 Strand: -
Source datasets	PRJNA401781
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3587923,EH38E2303144)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC146382:-62 AB527094:-62 GeneID: 26057 HGNC/MGI_ID: HGNC:23575 UniProt_ID: Nearer transcript ids and distances: BC043394:-161 BC004173:-173 ENST00000639793.1:-179 LF383978:-179 MA619555:-179 AF308285:-179 ENST00000358602.9:-192 ENST00000330838.10:-192 ENST00000561029.1:-192 NM_032217.5:-192 NM_015574.2:-192 NM_198889.3:-192 AK307581:-192 LF358950:222 MA594527:222 ENST00000558247.5:254 AB014597:254 view more...

Gene_name: ankyrin repeat domain 17 Gene_symbol: ANKRD17 Gene_synonyms: FLJ22206 GTAR KIAA0697 MASK2 NY-BR-16 Gene_source: HGNC:23575

TATA-Box annotation

---

Distance to TSS:	207
Nearest PromoterID:	NM_032217
Entrez ID:	26057
Nearest Unigene:	Hs.601206
Nearest Refseq:	NM_015574
Nearest Ensembl:	ENSG00000132466
Gene Name:	ankyrin repeat domain 17
Gene Alias:	GTAR|MASK2|NY-BR-16
Gene Type:	protein-coding
CpG%:	0.166667
GC%:	0.903226
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ANKRD17 p2@ANKRD17 p3@ANKRD17 p4@ANKRD17 p5@ANKRD17 p7@ANKRD17 p8@ANKRD17 p10@ANKRD17
Sample		p1@ANKRD17	p2@ANKRD17	p3@ANKRD17	p4@ANKRD17	p5@ANKRD17	p7@ANKRD17	p8@ANKRD17	p10@ANKRD17
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	21.82	1.56	4.09	6.82	1.56	0.00	1.95	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	26.91	3.64	2.23	5.87	1.01	0.00	0.81	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	23.15	3.86	2.70	3.47	1.35	0.00	1.35	0.96
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	14.14	2.91	2.08	5.61	0.83	0.00	1.04	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	20.70	3.37	4.05	8.10	0.90	0.00	0.22	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	18.02	3.68	3.49	4.85	1.74	0.00	1.74	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	19.17	6.75	5.23	8.06	2.40	0.65	0.44	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	15.26	4.12	4.36	7.02	1.94	0.48	1.21	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	16.24	4.27	4.92	6.41	0.85	0.21	0.85	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	21.45	3.48	4.64	6.96	5.22	0.58	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	19.00	4.85	6.47	9.30	4.04	0.00	2.02	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	19.51	7.72	4.47	5.29	4.88	0.41	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	7.41	5.64	2.10	3.71	0.64	0.16	1.29	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	6.31	4.81	1.65	4.21	1.50	0.45	1.50	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	5.93	6.15	1.32	4.83	0.44	0.00	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	7.29	5.03	0.50	4.78	0.50	0.25	0.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	4.80	4.15	1.75	2.18	1.09	0.22	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	7.17	5.06	1.69	2.53	0.84	0.00	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	6.93	6.40	4.80	4.27	1.60	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	8.12	3.61	2.26	3.46	0.30	0.00	1.05	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	8.55	5.75	0.94	3.21	0.67	0.00	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	11.05	4.14	3.63	4.32	1.38	0.35	1.04	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	8.40	3.88	2.20	3.62	0.78	0.26	0.78	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	6.55	5.34	2.67	2.18	0.73	0.00	1.21	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	5.93	4.64	1.55	1.55	0.00	0.26	0.77	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	6.96	4.43	4.11	2.22	0.63	0.00	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	6.04	3.30	2.20	3.30	1.10	0.00	2.20	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	10.37	4.48	1.41	2.36	2.12	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	6.95	5.49	1.45	3.07	0.48	0.00	0.81	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	7.60	3.08	1.63	3.62	0.54	0.00	1.09	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	6.49	2.72	1.26	2.72	0.63	0.00	2.09	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	6.06	2.93	1.56	3.91	1.17	0.00	0.59	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	8.44	3.17	1.06	2.53	0.42	0.00	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	8.91	3.46	3.63	3.13	1.32	0.00	0.82	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	6.17	2.99	0.93	2.43	0.75	0.00	0.56	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	7.47	3.07	2.49	4.79	0.19	0.19	0.96	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	7.97	2.86	1.23	3.68	0.20	0.00	1.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	7.86	3.43	1.61	1.81	0.20	0.00	1.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	8.10	3.24	2.16	3.78	1.08	0.00	1.62	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	8.16	2.64	0.96	2.88	0.00	0.24	0.96	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	5.18	3.29	2.12	3.29	1.18	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	8.64	2.05	1.61	3.37	0.44	0.00	0.73	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	7.17	2.53	1.27	3.16	0.84	0.00	1.05	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	5.94	2.62	1.40	5.24	0.17	0.00	0.35	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	6.63	3.21	0.80	4.42	0.60	0.00	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	7.21	3.95	0.93	4.19	0.47	0.47	0.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	6.00	2.64	0.96	3.36	0.24	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	7.75	4.77	1.79	2.98	0.00	0.00	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	6.94	3.59	0.96	2.15	0.96	0.00	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	4.85	3.84	1.01	5.05	0.61	0.00	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	6.15	2.46	1.84	5.53	0.00	0.00	0.82	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	5.34	3.78	1.78	4.45	0.67	0.00	2.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	83.95	13.99	83.95	13.99	27.98	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	5.32	2.84	0.71	2.84	0.35	0.35	1.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	4.64	2.98	1.33	2.98	0.33	0.00	1.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	15.94	5.03	8.39	5.03	5.03	0.00	5.03	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	7.81	5.97	1.84	5.51	1.38	0.46	1.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	2.92	3.24	1.94	2.59	0.00	0.00	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	1.93	1.61	0.64	1.28	0.00	0.00	1.93	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	4.40	2.51	3.77	4.71	0.94	0.00	2.51	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	2.82	1.41	0.00	2.82	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	1.68	2.80	0.00	1.12	0.56	0.00	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	8.76	3.18	6.37	6.37	1.59	0.00	4.78	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	3.74	1.02	4.76	6.12	1.02	0.00	1.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	2.27	2.27	1.62	2.60	0.97	0.00	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	4.97	2.48	3.19	1.42	0.00	0.00	1.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	80.82	16.16	64.66	16.16	48.49	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	102.67	31.59	63.18	23.69	15.79	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	3.90	0.00	5.85	0.49	0.49	0.00	1.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	3.97	3.97	3.97	0.50	1.49	0.00	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	6.57	2.35	2.35	0.00	0.94	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	3.64	1.66	8.61	2.65	0.33	0.33	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	2.78	1.24	2.47	1.24	1.55	0.00	1.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	2.45	1.22	4.59	0.92	0.31	0.00	1.22	0.00
Adipocyte - breast, donor1	11376-118A8	10.45	5.54	3.17	1.58	1.43	0.00	0.16	0.00
Adipocyte - breast, donor2	11327-117E4	9.30	6.58	2.25	3.05	0.80	0.16	1.76	0.32
Adipocyte - omental, donor1	11473-119C6	12.60	7.63	4.58	3.05	2.04	0.13	0.51	0.25
Adipocyte - omental, donor2	11474-119C7	2.99	6.73	0.75	1.49	0.75	0.00	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	8.04	4.69	0.67	1.34	1.34	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	7.02	1.91	0.00	1.28	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	1.10	2.20	4.40	2.20	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	7.23	2.26	4.52	0.00	1.81	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	7.99	4.00	2.09	1.56	1.22	0.00	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	24.25	12.13	3.72	3.32	1.17	0.00	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	20.33	11.84	2.83	2.83	0.26	0.00	1.03	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	14.50	10.87	3.62	1.95	1.12	0.00	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	23.51	13.52	3.53	2.94	1.18	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	23.97	12.31	4.83	3.86	1.61	0.00	0.32	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	20.66	8.71	4.20	2.26	0.32	0.00	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	14.40	5.87	2.67	3.73	0.53	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	15.02	5.01	2.23	0.56	2.23	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	7.49	4.99	2.08	1.25	1.66	0.00	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	14.07	6.53	2.51	1.76	0.50	0.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	10.14	4.91	2.62	1.31	0.98	0.00	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	10.66	6.39	2.74	3.96	2.74	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	4.64	1.33	0.88	0.66	0.22	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	1.43	2.15	0.00	0.36	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	1.20	1.20	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	6.12	2.16	1.62	1.44	0.36	0.00	0.18	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	1.67	1.67	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	3.29	2.88	1.03	1.03	0.41	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	9.15	6.87	5.15	1.03	2.17	0.00	0.46	0.00
Anulus Pulposus Cell, donor2	11463-119B5	6.37	7.10	1.71	0.24	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	5.39	3.15	0.45	1.80	2.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	6.51	3.04	1.30	0.00	1.74	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	2.14	2.14	2.14	0.00	0.00	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	5.68	1.20	2.39	2.09	0.30	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	8.85	3.79	5.06	1.26	1.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	4.62	1.32	0.66	0.66	1.98	0.00	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	6.50	2.92	1.95	2.27	0.65	0.00	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	4.85	5.34	1.46	1.94	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	4.16	5.34	3.56	0.00	0.00	0.00	0.00	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	4.90	1.13	2.26	1.88	0.38	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	7.26	1.45	0.73	0.00	0.00	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	3.76	0.00	2.51	3.76	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	5.77	3.29	3.13	0.99	0.82	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	5.46	4.09	1.36	0.00	2.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	2.56	1.06	0.60	1.36	0.15	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	3.21	3.75	0.00	1.07	2.14	0.00	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	4.72	3.40	2.08	1.32	0.76	0.00	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	5.61	2.94	2.41	0.80	0.00	0.00	0.80	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	3.90	0.00	0.98	1.95	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	5.97	2.49	2.65	0.83	1.16	0.00	0.33	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	6.00	6.00	0.00	2.40	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	0.00	0.00	3.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	6.52	4.12	0.86	1.54	0.34	0.17	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	4.19	4.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	2.91	2.91	2.43	0.97	0.00	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	6.07	4.55	0.38	0.76	1.52	0.00	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	0.00	3.63	3.63	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	5.70	2.28	1.14	0.57	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	5.56	5.34	1.28	1.71	0.86	0.00	0.43	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	4.39	2.58	1.55	0.77	0.52	0.00	0.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	6.57	3.28	1.41	1.41	0.00	0.00	1.41	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	4.50	4.82	2.57	1.93	0.64	0.00	0.96	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	2.14	2.14	1.43	2.14	0.71	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	1.75	1.75	1.75	1.17	0.00	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	3.01	4.52	1.81	1.81	1.20	0.00	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	2.38	5.94	3.56	2.38	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	4.58	2.03	2.54	1.53	2.03	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	7.90	3.06	2.80	1.02	0.76	0.00	0.76	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	3.81	1.27	3.81	0.64	0.64	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	7.34	2.59	1.73	1.73	1.29	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	5.50	3.60	1.69	1.06	0.64	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	2.61	2.32	0.58	0.58	0.29	0.00	0.87	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	4.72	1.89	1.89	0.00	0.00	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	4.75	4.58	2.20	1.02	0.34	0.00	0.68	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	0.00	4.63	0.00	2.32	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	14.79	2.11	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	7.08	2.79	3.00	1.50	0.43	0.00	0.21	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	3.61	4.21	1.20	1.20	0.60	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	4.37	2.19	1.46	0.73	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	5.52	2.99	2.99	0.92	0.69	0.00	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	2.55	2.55	0.00	0.00	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	3.05	1.78	1.27	1.02	0.51	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	4.54	4.34	1.24	1.03	1.45	0.00	0.21	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	3.98	2.45	3.67	0.92	1.53	0.00	1.53	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	4.78	0.96	2.39	1.43	0.48	0.00	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	6.43	4.21	0.89	1.11	0.44	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	1.53	3.05	1.53	0.00	1.53	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	3.88	2.22	1.66	2.22	1.66	0.00	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	4.24	3.71	1.85	2.38	0.79	0.00	0.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	5.09	1.45	2.91	1.09	0.00	0.00	0.73	0.00
Astrocyte - cerebellum, donor1	11500-119F6	8.60	2.70	0.98	1.35	0.86	0.00	0.00	0.25
Astrocyte - cerebellum, donor2	11580-120F5	4.79	2.74	0.51	2.40	0.34	0.00	0.17	0.34
Astrocyte - cerebellum, donor3	11661-122F5	2.10	2.73	0.21	1.26	0.21	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	20.92	11.15	8.02	4.88	5.23	0.00	0.35	1.39
Astrocyte - cerebral cortex, donor2	11316-117D2	21.52	11.81	6.31	7.44	4.21	0.00	1.13	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	20.73	8.80	4.03	4.62	2.09	0.00	0.30	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	19.15	19.61	1.61	22.94	3.67	0.11	0.69	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	17.54	20.17	2.38	24.68	2.26	0.13	1.00	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	18.89	19.00	1.48	24.01	3.19	0.34	0.46	0.11
Basophils, donor1	12241-129G9	8.63	4.97	4.18	6.28	0.52	0.00	0.00	0.00
Basophils, donor2	12242-129H1	22.01	6.86	10.10	10.46	2.89	0.00	0.00	0.00
Basophils, donor3	12243-129H2	15.14	9.55	3.82	3.38	1.32	0.00	0.59	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	3.45	1.72	0.65	0.22	0.43	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	2.29	0.91	0.00	0.46	0.00	0.00	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	14.35	7.17	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	6.90	2.51	0.63	1.88	1.26	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	2.91	2.50	0.83	1.66	1.66	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	5.99	2.07	0.69	0.23	0.69	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	12.42	6.66	1.62	1.44	0.90	0.00	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	31.74	15.87	0.31	10.92	0.52	0.00	0.41	0.93
Burkitt's lymphoma cell line:RAJI	10476-106I8	50.07	17.47	0.47	11.88	1.16	0.00	1.40	1.16
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	26.54	10.55	17.91	8.31	1.28	0.00	0.32	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	31.03	20.68	0.00	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	41.70	10.71	7.33	6.76	1.13	0.00	1.69	0.00
CD14+ Monocytes, donor2	11305-117B9	25.24	11.51	7.80	5.01	1.48	0.00	0.37	0.00
CD14+ Monocytes, donor3	11381-118B4	25.25	10.10	4.83	6.81	1.98	0.00	0.66	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	19.53	19.53	9.91	11.60	1.70	0.00	0.85	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	17.06	13.27	6.44	9.86	1.52	0.00	0.38	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	16.77	20.38	6.90	14.14	2.30	0.00	0.33	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	24.28	7.66	1.16	6.65	0.29	0.00	0.72	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	21.42	6.34	2.11	8.15	0.30	0.00	0.30	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	22.27	13.74	0.95	8.53	0.00	0.00	0.24	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	20.76	7.53	0.84	3.35	0.17	0.00	0.67	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	24.29	6.62	2.21	5.52	0.00	0.00	0.55	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	22.07	9.67	0.99	3.47	0.25	0.25	0.50	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	20.95	4.50	1.57	5.68	0.39	0.00	0.39	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	19.05	10.50	0.89	4.99	0.00	0.00	0.36	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	24.59	5.01	3.70	5.66	0.44	0.00	0.44	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	16.86	5.85	1.17	3.51	0.23	0.00	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	32.74	12.14	6.34	3.70	0.00	0.00	1.06	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	34.39	11.09	3.33	1.11	0.00	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	19.34	6.69	1.34	4.91	0.45	0.15	1.78	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	24.15	8.78	2.39	5.39	0.20	0.00	0.40	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	19.57	7.29	1.67	4.16	0.00	0.00	0.83	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	18.99	7.78	0.46	4.58	0.00	0.00	0.92	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	22.17	7.24	3.85	4.30	0.68	0.00	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	25.31	6.55	0.87	3.06	0.00	0.00	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	18.83	7.53	1.34	6.46	0.54	0.00	0.54	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	25.30	8.90	1.92	4.54	0.52	0.00	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	23.99	14.31	1.68	7.15	1.26	0.00	0.42	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	18.55	4.04	2.20	3.86	0.55	0.00	0.73	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	25.36	7.75	2.82	5.64	1.41	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	28.96	8.34	2.63	4.39	0.44	0.00	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	23.54	5.58	1.39	5.58	0.70	0.00	0.17	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	24.53	10.41	1.12	5.20	0.74	0.00	0.74	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	21.77	7.98	3.02	6.04	1.29	0.00	0.43	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	17.20	9.01	0.41	4.91	0.82	0.00	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	24.80	8.34	2.32	3.01	0.23	0.00	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	16.47	4.87	2.78	3.48	0.23	0.00	0.00	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	9.81	7.85	4.36	3.27	0.22	0.00	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	14.78	9.01	3.93	3.00	0.92	0.00	0.46	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	11.48	6.93	4.55	2.60	0.43	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	24.29	14.01	2.34	6.07	0.31	0.16	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	20.08	12.57	1.57	4.72	0.17	0.00	0.52	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	29.88	27.20	3.12	8.70	0.22	0.00	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	26.28	12.25	1.53	4.85	0.26	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	19.32	9.00	1.32	2.85	0.00	0.00	0.66	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	13.26	11.79	3.16	2.11	0.42	0.00	0.21	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	14.23	12.19	2.03	14.23	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	13.56	13.56	1.36	17.63	0.68	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	16.57	11.39	3.11	12.43	1.04	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	23.45	20.79	1.60	23.99	1.07	0.00	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	14.47	13.40	1.07	16.62	0.54	0.00	0.54	1.61
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	12.63	9.83	1.40	23.87	2.11	0.00	1.40	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	8.63	9.41	2.35	16.47	1.57	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	14.50	11.86	3.95	25.05	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	32.05	10.68	6.58	35.34	2.47	0.00	0.82	0.82
CD19+ B Cells, donor2	11624-122B4	24.66	7.25	7.98	14.51	2.18	0.00	1.45	0.73
CD19+ B Cells, donor3	11705-123B4	28.78	10.60	7.57	19.18	3.53	0.00	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	26.67	13.33	6.46	3.23	1.62	4.85	0.00	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	14.38	8.79	2.80	1.60	1.60	4.39	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	22.09	7.03	23.09	2.01	2.01	0.00	1.00	1.00
CD34+ Progenitors, donor2	11625-122B5	30.90	6.18	16.85	3.93	8.43	0.00	0.00	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	18.41	15.78	11.27	9.77	1.50	0.00	0.75	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	17.81	13.30	15.56	9.92	2.93	0.00	0.00	0.90
CD4+ T Cells, donor1	11225-116C1	67.13	28.21	35.35	15.35	5.36	0.00	0.36	0.36
CD4+ T Cells, donor2	11306-117C1	47.76	16.53	14.08	13.47	3.06	0.00	3.06	1.22
CD4+ T Cells, donor3	11382-118B5	33.24	16.77	16.77	13.72	3.96	0.00	1.83	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	16.85	17.61	11.23	6.64	4.85	0.00	0.51	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	17.97	12.35	12.35	8.09	1.12	0.00	0.67	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	14.66	14.09	7.19	8.05	3.45	0.00	0.00	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	24.65	17.07	12.80	21.81	0.95	0.00	0.95	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	23.88	12.64	9.83	23.88	6.32	0.00	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	29.67	16.48	13.18	6.59	3.30	0.00	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	17.05	7.95	7.95	5.93	3.61	0.00	0.58	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	16.95	13.22	7.46	6.95	2.37	0.00	1.19	1.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	13.22	15.96	5.00	8.06	2.26	0.00	1.29	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	15.69	4.03	8.52	10.31	1.79	0.00	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	16.07	5.94	4.54	10.13	0.35	0.00	1.05	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	19.36	9.24	10.56	15.84	2.20	0.00	2.20	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	18.55	13.07	10.54	5.48	4.22	0.00	2.11	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	16.21	12.88	4.16	8.52	1.87	0.00	1.04	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	7.02	7.02	3.68	8.02	0.67	0.00	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	27.47	18.22	15.50	14.14	5.44	0.00	0.82	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	27.33	12.86	17.69	16.08	3.22	0.00	1.61	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	30.48	26.90	3.59	16.14	1.79	0.00	5.38	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	23.73	13.72	9.27	7.05	3.71	0.00	0.19	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	15.60	10.83	3.90	5.42	2.38	0.00	0.65	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	18.49	8.62	3.99	9.67	2.10	0.00	0.63	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	28.82	15.67	13.65	15.17	1.01	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	31.19	14.30	13.00	12.56	0.87	0.00	1.30	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	27.46	18.74	13.95	13.07	3.49	0.00	1.31	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	22.27	17.32	6.43	20.78	2.97	0.49	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	14.77	13.85	5.54	12.92	0.92	0.00	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	19.54	18.15	5.58	5.58	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	34.34	24.92	3.88	11.35	1.94	0.00	0.28	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	24.29	19.14	7.61	14.23	2.21	0.00	0.00	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	32.34	18.48	7.70	26.18	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	22.92	21.85	8.24	16.83	1.07	0.00	0.36	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	23.54	9.69	2.77	11.08	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	42.56	18.99	17.35	14.41	1.64	0.00	1.96	0.33
CD8+ T Cells, donor2	11307-117C2	34.16	9.01	6.38	13.89	0.38	0.00	1.88	1.13
CD8+ T Cells, donor3	11383-118B6	47.97	19.69	13.38	19.19	2.02	0.25	1.01	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	4.59	2.06	1.84	2.06	0.69	0.00	0.69	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	4.07	3.35	1.92	2.40	0.24	0.00	0.72	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	3.56	3.28	2.19	3.01	0.27	0.00	1.37	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	4.80	0.90	0.90	3.30	1.50	0.00	1.50	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	6.00	5.52	1.68	2.64	0.48	0.00	0.96	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	4.78	5.68	1.36	2.27	0.68	0.00	0.45	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	8.47	2.39	2.39	7.17	0.00	0.22	0.43	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	4.21	1.05	1.05	2.90	0.53	0.00	0.79	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	7.97	4.22	1.88	3.05	0.00	0.00	0.70	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	6.94	3.62	0.91	4.83	1.21	0.00	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	5.81	3.20	1.45	6.10	0.29	0.00	2.03	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	10.66	6.13	1.60	5.86	0.53	0.00	0.80	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	8.32	3.50	3.06	5.25	1.31	0.00	0.88	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	8.20	5.01	2.28	6.38	0.00	0.46	0.00	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	5.22	4.48	1.49	0.75	0.00	0.00	0.00	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	5.76	3.24	2.16	1.80	1.44	0.00	1.08	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	6.33	3.16	2.01	2.01	0.29	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	4.71	3.54	0.94	3.54	0.94	0.00	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	7.92	3.80	1.58	2.85	1.58	0.00	0.63	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	6.77	3.08	1.54	2.46	0.00	0.00	0.62	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	7.69	4.17	1.28	3.85	0.96	0.00	1.28	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	4.97	1.91	1.91	3.06	1.15	0.00	0.76	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	7.88	3.55	1.97	3.15	0.39	0.00	0.39	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	4.54	3.03	1.51	1.51	0.00	0.00	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	13.65	4.82	6.42	6.42	2.41	0.00	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	11.89	4.20	4.20	8.39	4.90	0.00	0.70	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	13.02	4.01	4.01	11.02	2.00	0.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	18.28	5.48	0.00	5.48	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	5.93	4.94	0.99	3.46	2.47	0.00	1.48	0.00
Cardiac Myocyte, donor3	11686-122I3	8.84	3.47	2.32	1.26	1.16	0.00	0.11	0.21
Chondrocyte - de diff, donor1	11261-116G1	6.59	2.77	2.43	0.35	2.08	0.00	1.39	0.00
Chondrocyte - de diff, donor2	11338-117F6	10.66	2.84	2.13	1.07	0.36	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	8.76	4.78	1.37	1.37	0.57	0.00	0.46	0.11
Chondrocyte - re diff, donor2	11339-117F7	22.38	10.74	8.06	0.90	1.79	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	12.54	6.87	0.81	2.43	0.00	0.00	0.40	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	24.79	14.23	13.89	4.36	5.62	0.23	0.92	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	18.60	11.12	8.55	5.34	3.42	0.00	0.43	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	18.05	10.89	5.84	4.60	3.01	0.00	0.44	0.62
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	23.11	16.51	5.78	7.15	2.66	0.46	0.37	0.46
Corneal Epithelial Cells, donor1	11526-119I5	3.51	1.76	0.44	0.00	0.22	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	9.10	5.69	0.00	0.00	0.00	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	3.83	1.53	1.53	1.53	0.00	0.00	0.00	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	9.91	9.25	7.10	7.92	1.16	0.00	0.17	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	11.99	8.83	2.84	8.83	1.58	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	6.90	13.80	0.00	0.00	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	7.88	6.70	3.35	5.51	0.97	0.00	0.54	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	31.77	12.98	21.52	6.49	3.42	0.00	0.34	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	27.42	11.10	15.67	5.22	2.61	0.00	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	49.36	18.87	14.03	6.29	3.87	0.00	0.00	1.94
Endothelial Cells - Aortic, donor0	11207-116A1	8.34	4.17	3.67	3.34	0.33	0.00	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	5.28	4.69	1.17	1.17	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	9.90	5.09	1.13	2.26	0.28	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	5.50	7.08	0.39	2.36	0.39	0.00	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	4.07	5.24	1.75	1.75	0.58	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	9.41	8.23	1.41	4.24	0.71	0.00	1.18	0.00
Endothelial Cells - Artery, donor3	11413-118E9	8.77	5.61	3.33	1.93	0.00	0.00	0.00	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	17.07	10.42	5.32	3.77	1.77	0.00	0.22	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	13.69	14.60	10.35	5.17	1.22	0.00	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	14.38	13.25	7.33	5.36	0.56	0.00	0.56	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	3.86	3.86	0.59	1.19	0.30	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	6.77	2.60	4.17	1.56	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	3.54	3.40	1.84	1.99	0.43	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	12.80	8.00	4.00	1.20	0.00	0.00	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	7.34	6.29	0.52	3.67	0.52	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	25.10	14.54	11.55	5.72	2.61	0.00	0.00	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	18.03	14.77	5.00	5.21	1.09	0.00	0.43	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	26.62	11.97	4.27	5.98	1.71	0.00	0.24	0.12
Endothelial Cells - Vein, donor1	11267-116G7	4.55	3.41	2.28	3.41	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	9.08	2.79	0.70	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	10.68	5.50	1.26	3.30	0.00	0.00	0.16	0.16
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	56.11	24.75	0.00	11.55	1.65	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	49.94	39.24	0.00	7.13	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	3.18	0.73	0.24	0.24	0.24	0.00	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	9.85	6.16	3.69	2.46	1.23	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	2.30	0.66	0.66	0.55	0.00	0.00	1.09	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	2.17	1.41	1.30	1.08	0.43	0.00	1.84	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	11.16	4.61	7.76	2.30	1.82	0.00	0.61	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	30.43	15.83	12.69	5.87	4.91	0.00	0.68	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	8.33	6.01	2.32	1.69	1.05	0.00	0.53	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	18.97	16.60	3.69	8.17	3.43	0.00	0.53	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	12.96	6.31	4.32	4.32	1.33	0.00	0.66	0.00
Fibroblast - Cardiac, donor1	11268-116G8	7.71	4.54	2.72	2.72	0.45	0.00	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	7.58	5.31	1.52	1.52	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	7.10	3.47	1.58	1.89	0.16	0.00	0.16	0.16
Fibroblast - Cardiac, donor4	11452-119A3	26.37	12.43	6.67	5.76	2.42	0.00	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	11.04	7.61	2.79	2.03	1.27	0.00	0.00	0.13
Fibroblast - Cardiac, donor6	11460-119B2	14.40	8.34	4.09	3.94	1.67	0.00	0.15	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	15.94	7.24	1.74	1.61	0.67	0.00	0.13	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	12.51	9.06	3.02	2.16	0.43	0.00	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	0.00	5.86	2.93	1.46	4.39	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	3.92	3.00	1.15	0.92	0.92	0.00	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	9.50	8.82	4.24	2.37	2.71	0.00	0.51	0.17
Fibroblast - Dermal, donor1	11269-116G9	7.75	3.29	2.58	0.47	1.64	0.00	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	11.79	4.72	1.89	1.89	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	6.53	5.44	2.18	1.57	1.45	0.00	0.85	0.00
Fibroblast - Dermal, donor4	11450-119A1	10.97	6.78	4.18	1.58	2.94	0.00	0.11	0.23
Fibroblast - Dermal, donor5	11454-119A5	12.04	8.37	3.66	2.79	4.01	0.00	0.35	0.70
Fibroblast - Dermal, donor6	11458-119A9	13.64	10.56	3.09	3.90	3.25	0.00	0.49	0.32
Fibroblast - Gingival, donor1	11237-116D4	16.66	12.29	6.25	2.08	4.37	0.00	0.42	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	13.62	13.89	2.36	4.98	2.10	0.00	0.52	0.00
Fibroblast - Gingival, donor2	11318-117D4	13.97	8.83	3.69	4.09	2.50	0.26	0.53	0.40
Fibroblast - Gingival, donor3	11394-118C8	16.82	13.25	2.42	2.90	1.64	0.00	0.10	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	21.82	7.27	6.23	2.08	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	9.69	5.99	0.70	2.29	0.18	0.00	0.35	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	15.43	9.51	4.68	4.68	1.25	0.00	0.62	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	10.41	8.25	4.06	2.30	1.22	0.00	0.81	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	7.76	5.65	1.41	4.59	1.06	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	9.65	4.68	3.80	2.78	2.05	0.15	0.44	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	12.95	9.82	3.68	2.18	2.32	0.00	0.55	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	11.74	7.46	4.50	3.84	1.43	0.00	0.11	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	13.94	9.83	2.05	3.37	1.03	0.00	0.29	0.44
Fibroblast - Lung, donor1	11270-116H1	4.08	0.00	0.00	1.36	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	5.97	10.45	0.00	2.98	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	9.07	5.91	2.32	3.38	0.84	0.00	0.42	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	9.16	5.00	0.00	1.67	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	4.20	1.40	0.00	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	0.56	0.28	0.28	0.28	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	11.77	4.47	2.03	1.62	0.81	0.00	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	0.00	0.00	0.00	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	13.77	8.92	6.40	2.91	4.85	0.00	0.19	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	18.20	15.47	4.25	6.07	2.88	0.15	0.46	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	25.09	18.36	7.96	3.06	5.81	0.00	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	8.40	10.69	0.76	1.53	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	7.83	8.10	3.78	0.81	1.35	0.00	0.54	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	12.29	7.19	1.51	3.94	0.35	0.00	0.46	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	6.96	2.54	4.42	1.66	1.22	0.00	0.22	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	6.71	2.03	1.83	2.03	0.41	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	2.67	2.67	0.67	1.34	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	4.35	5.93	3.95	1.98	0.79	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	30.16	20.04	6.95	6.55	6.15	0.00	0.99	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	11.37	4.80	2.66	0.71	0.89	0.00	0.36	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	11.63	7.69	4.93	1.18	0.20	0.00	0.79	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	21.06	11.13	3.91	3.31	2.71	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	15.55	8.10	2.59	2.59	2.59	0.00	0.22	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	34.92	18.22	4.05	5.57	1.27	0.00	1.52	0.51
Fibroblast - skin normal, donor1	11553-120C5	12.14	4.59	2.30	0.82	0.33	0.00	0.49	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	24.06	19.05	13.83	7.62	7.62	0.20	0.60	0.20
Fibroblast - skin normal, donor2	11561-120D4	10.35	7.64	2.81	1.41	2.91	0.00	0.30	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	34.76	25.39	7.56	9.37	5.44	0.00	1.51	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	11.85	5.96	3.07	1.16	1.24	0.00	0.08	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	18.98	14.70	1.88	2.56	1.20	0.00	0.34	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	16.09	12.48	5.58	4.27	3.61	0.00	0.99	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	12.36	6.71	4.05	1.70	2.34	0.11	0.21	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	10.46	4.55	2.70	1.35	1.52	0.00	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	3.45	1.41	1.41	0.94	0.16	0.00	0.78	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	66.48	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	27.02	12.20	6.10	0.00	3.49	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	10.05	4.85	2.43	1.56	0.87	0.00	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	16.66	5.47	5.99	2.08	1.82	0.00	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	12.78	6.64	3.07	3.83	3.58	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	12.25	5.36	0.00	6.12	0.00	1.53	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	9.57	3.83	0.00	3.19	0.00	1.28	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	18.26	8.84	0.57	13.98	0.29	0.00	1.14	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	15.44	13.24	0.83	22.34	3.03	0.00	1.65	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	16.21	9.82	5.71	16.67	5.71	0.00	0.91	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	16.25	8.52	0.99	16.25	0.79	0.00	0.99	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	13.75	12.16	1.59	23.00	3.70	0.00	1.59	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	12.72	9.46	2.94	21.53	4.57	0.33	1.63	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	13.27	12.82	0.44	15.48	0.00	0.00	1.77	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	12.72	9.19	0.57	6.22	0.71	1.13	0.14	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	15.76	12.56	2.59	7.14	1.35	0.37	0.74	1.23
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	9.94	8.33	0.54	4.03	1.07	0.54	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	16.60	9.29	1.61	4.58	0.37	0.00	0.37	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	13.70	8.44	0.42	4.29	0.55	0.83	0.55	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	14.03	6.10	0.00	3.05	0.00	0.41	1.22	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	11.41	7.76	1.60	4.11	0.68	0.23	0.68	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	13.83	7.97	1.12	4.48	0.87	0.00	0.37	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	11.58	9.62	1.09	8.96	0.44	0.22	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	10.93	5.02	2.36	3.25	1.48	0.30	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	14.62	8.11	2.07	3.97	2.07	0.16	0.79	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	9.16	9.83	1.12	5.14	1.12	0.89	1.12	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	12.10	7.86	1.61	3.02	1.21	0.00	1.01	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	19.85	9.50	3.22	4.24	1.70	0.00	1.19	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	17.56	8.69	2.66	5.50	1.95	1.24	0.27	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	13.32	7.18	4.89	4.89	4.99	0.10	0.31	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	12.81	5.98	3.76	4.27	5.29	0.17	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	19.36	9.07	3.54	6.53	1.88	0.11	0.89	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	21.80	6.07	4.16	4.49	2.66	0.83	0.42	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	19.81	8.17	3.68	2.45	2.86	0.41	0.20	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	11.76	7.01	2.89	4.95	1.86	0.00	0.62	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	17.99	9.22	2.65	4.15	1.27	0.00	0.69	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	17.01	7.67	2.84	5.00	1.67	0.33	0.17	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	11.68	3.75	2.42	2.42	0.88	0.44	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	20.79	7.26	2.95	4.30	2.09	0.00	0.74	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	20.26	8.92	2.76	5.35	1.78	0.00	0.49	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	16.04	8.66	5.77	6.74	2.25	0.32	0.64	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	14.50	7.11	3.41	3.32	2.08	0.00	0.57	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	11.71	5.22	1.58	3.01	3.01	0.00	0.47	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	16.42	5.47	1.22	2.43	0.61	0.30	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	15.68	6.69	2.82	5.54	1.46	0.00	0.31	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	13.39	5.93	3.29	5.05	2.63	0.00	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	11.78	7.01	3.37	3.37	1.68	0.00	1.40	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	15.28	5.65	2.41	4.54	1.02	0.00	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	9.89	6.15	1.87	4.81	1.60	0.27	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	13.01	5.36	0.92	3.37	1.22	0.46	0.46	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	10.75	6.87	2.07	3.76	1.42	0.00	0.39	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	13.55	6.51	1.90	5.15	0.81	0.00	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	13.64	4.79	1.47	4.42	1.66	0.00	0.55	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	17.33	8.77	2.19	2.41	0.88	0.22	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	17.85	13.88	2.98	5.95	3.97	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	9.10	4.75	2.24	3.17	0.53	0.00	0.26	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	13.11	7.87	1.82	2.42	1.01	0.00	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	23.89	11.69	4.83	5.85	5.59	0.51	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	25.28	17.92	0.00	9.16	0.40	0.40	0.20	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	16.95	14.48	0.15	7.24	0.46	0.00	0.15	0.92
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	23.53	16.16	0.41	10.43	0.20	0.20	0.61	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	8.14	1.88	0.00	2.19	0.00	0.00	0.31	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	9.32	2.83	0.28	2.83	0.28	0.00	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	21.68	12.91	0.00	9.69	0.46	0.46	1.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	2.47	7.42	0.00	7.42	0.00	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	17.79	6.58	0.39	5.03	1.16	0.77	2.71	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	14.44	12.84	0.00	9.63	0.00	0.00	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	29.56	8.69	1.74	15.65	1.74	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	19.85	8.79	0.00	5.53	0.33	0.65	1.95	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	21.41	11.53	0.82	4.53	0.00	2.06	2.88	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	13.33	0.00	6.66	0.00	6.66	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	19.58	8.39	0.28	5.59	0.00	1.12	3.08	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	16.67	7.84	0.65	4.25	1.63	1.63	2.61	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	14.26	5.87	0.00	3.36	0.00	0.00	3.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	21.63	9.22	0.32	7.00	0.95	2.86	1.27	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	13.59	6.11	1.02	5.43	0.34	3.74	1.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	10.44	6.26	0.00	6.26	2.09	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	16.04	13.74	0.00	7.45	0.57	0.00	1.72	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	10.95	4.44	0.00	2.96	0.59	0.89	1.18	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	16.94	8.47	1.69	5.08	1.69	0.00	5.08	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	26.51	9.53	2.49	7.04	1.24	4.56	3.31	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	16.34	10.36	0.23	6.21	1.61	1.61	0.92	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	31.61	5.27	5.27	5.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	14.99	9.23	0.77	6.15	0.77	1.92	1.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	18.58	6.19	0.65	4.89	0.98	4.56	0.98	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	8.69	4.68	2.01	3.34	0.67	1.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	26.20	14.25	1.16	4.24	1.54	1.16	2.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	31.15	8.90	1.37	7.19	0.68	9.24	3.08	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	22.36	2.48	0.00	4.97	0.00	0.00	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	9.91	11.32	0.00	3.30	0.94	2.36	1.42	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	19.31	10.86	0.60	3.62	0.00	4.83	3.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	14.75	8.14	0.51	1.02	2.54	0.51	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	16.75	7.98	0.00	5.98	2.39	1.99	1.60	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	15.79	8.39	1.48	5.92	1.97	5.92	2.96	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	31.87	16.53	2.36	12.98	5.90	4.72	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	15.75	7.58	1.17	5.83	0.58	2.92	2.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	23.70	11.85	3.07	8.78	3.07	4.83	1.32	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	42.38	8.48	0.85	5.93	0.85	1.70	2.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	12.54	8.36	1.19	5.97	1.79	1.19	0.60	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	17.95	4.85	0.97	3.88	1.94	0.49	3.88	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	13.70	7.99	2.28	0.00	0.00	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	12.47	7.90	2.08	5.41	0.00	0.00	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	5.62	2.25	6.75	2.25	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	6.66	5.71	1.59	1.59	0.63	0.00	0.95	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	2.92	4.18	0.00	0.84	0.42	0.00	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	2.32	4.18	1.51	2.79	1.04	0.35	0.35	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	4.39	3.21	1.86	1.69	1.18	0.00	0.84	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	2.96	3.19	2.28	2.28	1.14	0.23	0.68	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	3.39	3.39	1.97	2.40	0.98	0.11	0.77	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	2.79	3.44	1.50	2.15	0.86	0.21	0.43	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	2.37	5.38	0.65	0.65	0.86	0.65	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	3.11	2.74	1.37	1.87	0.62	0.25	0.25	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	2.74	3.26	1.03	1.03	0.00	0.00	0.17	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	2.88	3.84	1.28	1.60	0.32	0.00	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	3.92	2.24	0.00	2.24	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	3.03	0.87	0.87	0.43	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	7.93	5.29	2.64	0.00	0.00	5.29	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	6.35	3.53	1.06	1.06	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	3.63	0.73	0.73	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	4.20	3.32	2.27	1.57	0.17	0.17	1.75	0.00
Hepatocyte, donor1	11523-119I2	14.53	12.11	0.00	6.05	0.00	21.79	1.21	2.42
Hepatocyte, donor2	11603-120I1	31.24	7.54	0.00	3.23	0.00	0.00	2.15	0.00
Hepatocyte, donor3	11684-122I1	16.57	11.66	1.84	4.29	1.84	14.11	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	40.47	15.01	3.92	12.40	2.61	0.00	0.65	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	25.52	5.24	3.67	2.97	1.57	9.61	1.05	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	7.13	5.49	5.21	2.33	1.92	0.27	0.00	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	15.92	3.18	35.02	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	6.68	6.68	26.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	54.17	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	16.61	2.77	1.38	23.53	1.38	0.00	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	7.51	0.00	10.01	2.50	0.00	2.50	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	23.74	0.00	23.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	15.38	15.38	0.00	35.88	2.56	2.56	2.56	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	9.14	4.57	13.71	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	17.87	9.75	1.62	24.36	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	13.34	8.34	3.33	26.68	0.00	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	0.00	0.00	7.26	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	26.47	7.94	2.65	34.41	2.65	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	12.20	8.87	2.22	15.52	3.33	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	20.95	10.48	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	14.49	3.15	3.78	20.16	2.52	0.00	0.00	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	18.56	12.37	4.64	15.47	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	24.55	10.98	5.81	22.61	3.23	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	19.32	8.05	6.44	38.64	3.22	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	11.95	0.00	0.00	0.00	0.00	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	22.00	10.59	3.26	26.89	4.89	0.00	0.00	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	22.25	12.17	6.72	19.31	2.52	0.00	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	14.37	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	25.72	8.04	4.82	28.13	0.80	0.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	13.85	8.31	3.69	16.62	0.92	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	14.63	8.02	2.36	13.69	1.42	0.00	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	19.95	5.44	0.91	19.95	0.91	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	14.74	0.00	29.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	18.29	16.14	5.38	24.75	0.00	0.00	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	22.87	13.98	5.08	38.11	2.54	0.00	1.27	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	16.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	24.87	11.48	1.28	19.13	1.28	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	14.58	21.87	0.00	25.52	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	17.85	9.28	2.86	32.13	0.71	0.00	0.71	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	26.55	19.91	0.00	39.82	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	20.85	0.00	83.39	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	10.19	6.17	2.47	16.36	0.31	0.31	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	14.05	8.78	1.76	28.10	3.51	0.00	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	9.43	3.14	0.00	25.15	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	20.17	15.30	2.78	28.51	2.78	0.00	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	8.85	4.43	0.00	17.70	2.21	2.21	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	3.24	0.00	22.69	0.00	3.24	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	12.21	3.49	2.62	16.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	4.50	2.25	4.50	22.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	10.45	3.48	17.42	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	6.40	10.67	0.00	11.73	3.20	0.00	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	9.70	13.85	1.39	22.17	0.00	0.00	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	5.70	19.95	2.85	17.10	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	12.89	9.20	3.68	16.57	2.76	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	0.00	6.05	12.10	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	12.42	0.00	18.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	8.46	5.29	1.06	15.86	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	11.83	5.96	7.34	1.47	3.84	0.00	0.41	0.16
Keratinocyte - epidermal, donor2	11349-117G8	7.03	1.76	0.59	0.00	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	9.65	5.68	2.46	2.18	1.42	0.00	0.57	0.09
Keratinocyte - oral, donor1	11251-116E9	17.94	9.65	5.79	2.27	5.22	0.00	0.45	0.11
Keratocytes, donor1	11527-119I6	3.78	2.41	1.72	1.72	0.34	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	1.17	0.00	0.00	2.34	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	10.28	6.32	2.17	2.57	0.20	0.00	0.40	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	46.16	28.57	8.79	15.39	6.59	0.00	2.20	2.20
Lens Epithelial Cells, donor1	11529-119I8	7.55	2.16	2.16	0.00	0.00	0.00	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	13.15	6.00	4.38	2.54	3.46	0.00	0.12	0.12
Lens Epithelial Cells, donor3	11690-122I7	15.24	10.39	3.43	3.13	1.41	0.00	0.50	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	6.17	4.15	6.05	2.49	2.02	0.00	0.24	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	4.19	2.51	3.07	1.12	0.56	0.00	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	6.30	3.62	5.19	1.89	1.26	0.16	0.63	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	5.91	1.61	4.84	0.54	1.08	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	5.36	4.41	3.47	1.58	0.32	0.00	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	2.91	2.37	3.02	1.29	0.11	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	7.80	4.10	2.87	1.64	1.23	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	1.52	2.02	2.78	1.26	0.25	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	4.64	2.39	4.36	1.83	0.42	0.00	0.42	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	5.14	2.77	5.93	2.77	1.58	0.00	1.98	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	4.07	3.10	3.30	2.52	0.58	0.00	0.78	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	2.78	2.04	1.85	0.93	0.37	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	6.62	6.27	3.48	0.35	1.05	0.00	0.35	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	5.96	3.10	3.58	1.91	1.19	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	4.81	1.65	2.47	0.69	0.14	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	3.70	5.54	6.16	2.46	0.31	0.00	0.31	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	2.81	1.87	2.49	1.87	0.31	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	5.31	3.29	4.21	1.65	0.91	0.00	0.18	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	3.95	3.62	3.62	1.32	1.65	0.00	0.66	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	3.81	2.34	2.05	1.46	0.29	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	3.73	2.24	1.99	0.50	0.75	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	7.76	5.33	5.33	0.97	0.00	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	5.12	5.39	3.23	3.50	2.15	0.00	1.08	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	4.39	2.88	2.88	1.51	0.30	0.00	0.45	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	5.18	3.63	4.67	0.00	0.00	0.00	1.56	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	5.65	4.40	5.86	2.72	1.05	0.00	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	4.36	2.71	3.16	0.90	0.90	0.00	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	4.13	5.50	2.75	1.38	1.38	0.00	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	6.77	2.63	3.01	2.07	0.75	0.00	0.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	4.14	2.97	2.33	1.27	0.00	0.00	0.64	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	3.88	3.39	2.42	1.94	0.00	0.00	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	2.98	2.32	3.64	0.99	0.99	0.00	0.33	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	4.09	2.11	2.73	1.36	0.50	0.00	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	7.03	7.03	6.29	3.33	1.11	0.00	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	6.18	3.21	1.73	0.99	1.24	0.00	0.99	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	3.44	2.34	2.47	1.79	0.96	0.00	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	5.15	5.15	5.79	1.29	0.32	0.00	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	9.13	6.39	4.87	1.83	0.30	0.00	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	5.04	4.90	5.46	1.26	1.26	0.00	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	6.04	2.13	4.62	2.13	0.00	0.00	1.78	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	1.94	1.94	2.91	1.45	1.45	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	2.49	1.40	2.33	0.78	0.62	0.00	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	3.94	4.30	3.22	1.43	0.00	0.00	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	3.59	4.25	2.61	1.63	0.00	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	2.83	1.65	2.12	0.71	0.24	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	5.94	4.95	6.31	2.97	0.50	0.00	0.37	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	3.33	4.10	1.54	1.02	0.51	0.00	0.26	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	4.77	2.69	1.49	2.69	0.30	0.00	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	4.53	4.53	0.00	4.53	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	9.21	3.84	0.77	3.07	0.00	0.00	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	2.23	6.68	0.74	4.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	7.62	3.81	0.42	4.23	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	8.44	4.92	0.70	7.74	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	3.74	0.93	0.00	5.60	0.00	0.00	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	5.15	2.58	0.52	2.58	0.52	0.00	1.55	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	9.52	2.38	0.00	3.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	6.11	5.43	0.68	2.04	0.45	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	5.53	2.91	0.87	1.16	0.87	0.00	1.16	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	10.35	2.25	0.90	0.90	0.90	0.00	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	7.32	5.15	0.81	1.90	0.81	0.14	0.41	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	4.62	4.11	1.03	3.08	0.00	0.00	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	7.76	7.41	0.35	2.47	0.71	0.00	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	3.33	8.66	0.00	4.00	0.00	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	9.17	6.62	1.02	5.09	1.02	0.00	4.58	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	7.20	6.67	0.53	3.47	0.27	0.00	0.80	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	7.94	7.75	0.38	4.16	0.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	4.91	3.68	1.84	4.29	1.23	0.00	1.84	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	11.42	2.45	0.82	4.89	0.00	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	10.00	7.29	0.62	1.67	0.21	0.00	1.04	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	6.17	3.36	1.40	4.20	0.28	0.00	1.68	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	4.12	7.21	0.00	3.09	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	12.48	8.42	0.00	2.61	0.29	0.00	2.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	7.77	4.78	0.60	3.59	0.00	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	11.62	3.87	1.11	1.11	0.55	0.00	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	8.84	5.66	0.71	4.95	0.35	0.00	2.83	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	9.22	5.53	0.37	1.84	0.37	0.00	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	12.66	6.91	0.00	3.45	0.00	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	8.44	5.76	0.38	3.07	0.00	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	6.79	6.79	0.57	5.10	0.57	0.00	1.70	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	5.74	5.74	0.00	4.92	0.82	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	9.49	5.87	0.00	3.16	0.45	0.00	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	7.90	4.31	0.72	5.03	0.00	0.00	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	4.48	2.99	0.00	4.48	0.75	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	10.03	7.06	1.49	2.97	0.00	0.00	2.23	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	7.32	6.46	0.43	1.29	0.00	0.00	1.72	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	12.84	5.99	0.86	2.57	0.00	0.00	1.71	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	6.33	6.66	0.00	4.33	0.67	0.00	2.67	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	7.24	2.41	0.60	4.22	0.00	0.00	1.81	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	5.69	9.95	0.00	3.55	0.00	0.00	1.42	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	6.87	5.50	0.00	4.47	0.34	0.00	1.37	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	5.90	8.05	0.54	4.29	0.00	0.00	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	5.39	5.39	0.00	5.39	0.00	0.00	1.35	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	9.63	9.26	0.37	2.59	0.00	0.00	2.96	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	13.96	16.28	0.00	2.33	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	5.29	3.17	0.00	4.23	0.00	0.00	3.17	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	13.61	6.00	0.40	6.40	0.00	0.00	2.40	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	5.09	6.54	0.00	4.36	0.73	0.00	1.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	13.80	3.83	0.00	9.96	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	5.92	6.91	1.48	6.91	0.00	0.00	3.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	4.70	3.76	0.00	6.59	0.94	0.00	0.94	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	5.03	8.55	0.50	7.54	1.01	0.00	1.01	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	13.97	8.56	0.90	7.66	0.90	0.00	1.35	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	6.88	0.00	0.00	5.16	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	10.24	4.90	0.45	4.90	0.00	0.00	3.12	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	9.38	6.65	0.78	7.04	0.39	0.00	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	8.58	7.26	0.66	1.98	0.00	0.00	3.30	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	10.90	7.26	0.52	6.23	0.00	0.00	1.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	12.69	4.81	0.88	3.94	0.44	0.00	1.75	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	10.06	6.15	0.00	2.80	0.00	0.00	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	10.16	6.62	0.44	9.27	0.00	0.00	0.44	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	12.34	5.79	0.77	3.47	0.00	0.00	2.70	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	8.10	5.06	1.52	2.53	0.00	0.00	1.01	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	11.05	5.77	0.00	2.88	0.00	0.00	0.48	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	10.73	6.36	0.40	2.78	0.00	0.00	1.59	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	6.68	7.29	0.00	2.43	0.00	0.00	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	6.23	3.46	0.00	6.23	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	10.64	8.36	0.76	2.66	0.38	0.00	2.66	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	11.88	7.75	0.00	5.16	0.52	0.00	2.58	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	3.02	5.44	0.60	0.60	0.60	0.00	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	8.56	8.24	0.32	5.07	0.95	0.00	1.27	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	11.73	9.06	0.00	2.67	0.53	0.00	2.13	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	7.47	1.72	0.57	5.17	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	14.91	6.69	0.00	8.23	0.00	0.00	1.03	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	9.20	7.78	1.41	3.54	0.00	0.00	1.41	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	7.94	2.84	0.00	1.13	0.00	0.00	1.70	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	10.40	6.66	0.42	2.91	0.83	0.00	1.25	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	5.48	2.35	1.57	1.57	0.00	0.00	2.35	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	7.52	1.25	0.84	2.09	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	7.90	4.65	1.39	3.25	0.93	0.00	1.39	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	4.68	3.35	0.00	4.68	0.00	0.00	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	6.95	4.81	0.00	3.74	0.00	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	9.70	5.66	0.00	2.02	0.00	0.00	1.21	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	4.59	3.67	0.00	5.51	0.92	0.00	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	15.11	8.89	0.00	7.11	0.00	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	10.83	7.41	1.71	3.42	0.00	0.00	1.14	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	8.44	7.67	0.77	4.60	0.77	0.00	3.07	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	8.75	0.55	0.00	4.38	0.00	0.00	0.00	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	8.91	7.57	0.00	4.45	0.00	0.00	2.23	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	8.58	7.28	0.78	3.12	0.78	0.00	1.04	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	5.97	5.97	0.00	5.30	0.00	0.00	3.32	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	12.47	4.16	2.08	6.24	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	11.17	10.71	13.45	4.10	3.19	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	7.34	6.42	7.52	1.84	1.84	0.00	0.18	0.18
Macrophage - monocyte derived, donor3	11389-118C3	9.83	8.65	6.55	4.72	1.70	0.00	0.13	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	4.25	2.66	3.19	0.53	2.12	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	9.35	5.07	10.93	2.06	2.38	0.00	0.16	0.00
Mallassez-derived cells, donor3	11930-125I4	11.12	3.47	6.12	2.22	3.06	0.14	0.56	0.00
Mammary Epithelial Cell, donor1	11273-116H4	13.55	4.98	8.07	1.00	5.38	0.00	0.10	0.10
Mammary Epithelial Cell, donor2	11350-117G9	14.19	3.76	4.63	1.16	2.03	0.00	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	3.49	2.74	0.50	2.74	0.25	0.00	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	34.57	15.59	242.02	2.71	43.39	0.00	0.00	2.03
Mast cell, donor1	11563-120D6	14.27	12.44	14.82	5.08	2.38	0.00	0.76	0.65
Mast cell, donor2	11565-120D8	28.53	30.31	21.10	4.46	4.46	0.00	0.30	0.00
Mast cell, donor3	11566-120D9	28.37	42.32	31.97	6.75	2.93	0.00	0.68	0.00
Mast cell, donor4	11567-120E1	24.82	39.18	24.82	5.14	3.37	0.00	0.00	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	11.20	11.87	22.84	4.99	5.21	0.55	0.44	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	11.67	7.59	16.93	2.33	1.75	0.00	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	10.44	15.14	14.34	4.59	3.33	0.11	0.46	0.57
Mast cell, expanded, donor8	11941-126A6	12.89	17.57	11.21	7.87	1.51	0.00	0.84	0.17
Melanocyte - dark, donor1	11502-119F8	6.07	4.08	4.78	1.29	0.60	0.00	0.10	0.20
Melanocyte - dark, donor2	11582-120F7	6.92	4.85	2.08	5.19	0.35	0.00	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	14.56	6.01	2.83	4.20	3.40	0.00	0.51	0.14
Melanocyte - light, donor1	11274-116H5	7.76	2.59	1.88	0.94	1.65	0.00	0.24	0.24
Melanocyte - light, donor2	11351-117H1	6.82	2.73	2.05	1.36	0.68	0.00	0.68	0.00
Melanocyte - light, donor3	11423-118G1	6.07	5.20	0.00	5.20	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	12.08	6.77	1.98	2.92	1.77	0.00	0.31	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	9.95	5.11	2.15	1.61	2.69	0.00	0.81	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	15.27	9.37	4.02	4.55	2.95	0.00	1.61	0.00
Meningeal Cells, donor1	11493-119E8	9.92	5.21	2.36	2.11	1.49	0.12	0.12	0.37
Meningeal Cells, donor2	11573-120E7	4.84	7.48	1.76	2.20	2.20	0.00	0.44	0.44
Meningeal Cells, donor3	11654-122E7	9.45	6.19	8.97	2.36	3.18	0.00	0.33	0.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	6.84	3.99	4.28	2.28	4.28	0.00	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	11.17	6.74	6.14	1.81	1.01	0.00	0.50	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	0.00	1.31	0.00	2.63	0.00	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	2.62	1.31	3.92	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	7.89	2.87	2.87	1.44	2.15	0.00	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	7.84	6.78	3.60	1.91	1.06	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	4.02	5.53	1.51	2.51	0.50	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	3.74	1.54	2.20	2.20	1.10	0.22	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	5.11	2.92	0.73	2.19	0.73	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	3.48	1.64	0.61	2.86	0.41	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	8.31	9.83	1.94	1.66	2.91	0.00	0.28	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	2.97	1.12	0.37	0.74	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	8.03	5.00	4.34	1.58	2.76	0.13	0.26	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	3.56	3.26	0.59	0.59	2.08	0.00	1.19	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	0.00	2.34	0.00	0.00	0.00	4.67	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	2.56	2.56	2.56	2.56	0.64	0.00	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	7.80	4.96	4.61	1.42	2.48	0.00	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	9.69	5.00	4.07	1.25	3.44	0.00	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	8.71	5.08	2.18	2.18	1.45	0.00	0.73	0.73
Mesothelial Cells, donor1	11247-116E5	11.67	10.08	7.96	0.80	1.59	0.00	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	9.01	5.00	2.50	1.00	0.50	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	7.95	6.72	3.47	0.79	1.08	0.00	0.58	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	29.71	12.15	8.10	5.40	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	6.40	7.63	5.66	5.66	2.22	0.00	0.49	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	8.24	8.24	3.53	3.83	0.59	0.00	0.59	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	34.57	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	5.58	5.89	4.34	1.86	1.24	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	6.85	6.43	6.22	2.07	1.87	0.00	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	16.21	6.95	0.00	2.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	7.76	7.76	4.75	2.75	2.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	12.10	6.05	6.52	3.72	1.86	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	9.14	6.50	2.24	2.64	1.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	9.11	7.13	6.34	3.96	1.19	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	5.31	6.19	2.65	1.77	0.88	0.00	1.77	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	7.60	8.74	3.80	4.56	1.14	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	15.79	6.58	2.63	2.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	5.94	5.94	3.82	2.76	1.06	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	9.21	10.13	1.84	1.84	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	7.75	4.17	3.58	2.98	0.30	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	16.77	11.74	3.35	10.06	1.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	4.27	5.52	3.01	2.01	1.25	0.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	6.89	4.99	4.75	2.61	1.19	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	8.29	4.42	1.11	1.11	0.55	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	5.76	2.30	3.91	2.07	0.23	0.00	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	5.68	3.37	4.00	4.00	1.68	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	4.28	4.28	3.26	2.65	0.82	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	3.86	3.65	3.43	1.29	1.29	0.00	0.64	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	5.78	7.34	2.67	2.67	0.22	0.00	0.89	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	41.27	0.00	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	6.35	3.50	1.75	3.07	0.44	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	9.63	8.11	1.01	1.52	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	4.97	0.00	0.00	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	5.16	3.26	1.90	2.72	0.82	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	5.88	5.00	4.12	1.18	0.59	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	5.45	7.63	4.36	3.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	4.81	2.40	1.92	1.92	0.96	0.00	0.96	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	6.00	3.60	4.80	3.60	0.00	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	17.83	1.37	4.11	0.00	0.00	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	6.51	2.50	0.50	1.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	26.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	14.27	10.19	2.04	4.08	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	4.82	5.69	1.75	1.31	1.75	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	8.83	8.83	2.21	5.52	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	3.20	9.61	1.28	10.89	1.28	0.00	0.00	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	5.70	2.23	1.98	0.99	0.50	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	9.74	9.05	1.39	3.48	0.00	0.70	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	15.47	4.42	8.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	2.74	2.74	2.74	2.05	0.00	0.00	0.68	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	13.13	7.00	2.19	3.06	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	12.78	9.23	2.49	8.17	0.36	0.00	0.00	1.07
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	4.49	3.93	4.49	3.09	1.12	0.56	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	8.31	7.07	1.25	1.25	0.83	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	5.83	8.16	1.75	6.41	0.58	0.00	0.00	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	4.52	3.62	2.11	3.02	0.30	0.30	0.60	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	7.10	3.76	5.01	1.25	1.25	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	7.22	0.00	21.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	9.24	4.62	3.69	3.69	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	10.24	7.97	6.26	2.28	0.57	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	8.15	4.56	5.94	3.45	0.69	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	4.15	2.59	4.66	2.07	0.26	0.00	0.52	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	7.72	5.58	3.86	2.57	0.43	0.86	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	12.07	8.26	0.64	4.45	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	9.07	5.60	3.74	3.20	0.80	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	10.18	6.88	6.88	2.10	0.90	0.60	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	8.19	7.20	5.51	2.97	0.57	0.00	0.14	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	4.78	1.27	3.82	2.23	0.96	0.00	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	7.74	6.19	7.96	3.98	1.33	1.55	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	11.76	10.24	2.65	6.45	0.38	0.38	0.00	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	6.82	3.98	7.39	3.69	0.85	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	7.87	6.88	5.65	1.97	0.98	0.74	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	19.55	9.78	1.30	6.52	0.65	0.00	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	6.76	3.23	7.94	2.65	1.76	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	10.09	7.50	5.77	4.32	1.73	0.29	0.29	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	11.54	11.54	6.59	2.47	1.24	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	12.21	5.36	5.66	3.87	0.89	0.30	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	3.77	0.00	0.00	0.00	0.00	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1.78	1.78	1.78	1.78	0.00	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	4.93	4.93	5.26	1.64	0.99	0.00	0.99	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	3.16	1.05	1.05	1.05	0.00	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	3.76	3.95	2.77	2.37	1.58	0.00	0.59	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	7.45	3.73	0.93	5.59	0.00	0.00	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	2.63	3.38	6.01	3.38	1.50	0.00	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	3.46	2.66	2.40	1.60	0.27	0.00	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	7.46	4.41	3.96	1.81	1.24	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	2.95	1.47	2.95	0.74	0.00	0.00	1.47	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	3.66	3.66	2.93	0.73	1.10	0.00	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	4.67	6.22	4.67	1.56	0.00	0.00	3.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	2.67	2.67	1.60	0.53	1.07	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00	0.00	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	2.02	2.02	2.02	6.06	2.02	0.00	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	2.11	0.84	1.26	1.69	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	12.26	8.17	0.00	1.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	0.00	1.91	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	2.43	2.43	0.00	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	6.04	4.53	3.02	1.51	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	85.65	57.10	22.84	5.71	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	16.31	9.79	19.57	0.00	0.00	0.00	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	0.00	0.00	0.00	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	12.28	5.60	3.45	1.29	0.86	0.00	0.86	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	8.88	5.75	0.52	1.05	2.09	0.00	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	1.33	0.67	0.00	1.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	2.92	0.42	0.00	2.09	0.42	0.00	0.83	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	4.94	3.80	3.99	9.89	1.33	0.38	0.38	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	20.75	12.77	3.19	6.38	1.60	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	1.36	0.68	0.00	1.36	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	34.92	12.86	14.70	5.51	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	0.42	0.42	0.42	2.09	0.42	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	2.79	2.09	0.93	2.79	0.46	0.00	0.46	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	2.16	1.62	1.08	2.16	0.27	0.27	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	7.57	8.83	2.94	2.73	0.63	0.21	0.21	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	111.35	22.27	22.27	11.13	22.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	4.47	2.98	0.50	1.99	0.00	0.00	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	2.98	1.62	1.08	2.44	0.54	0.00	1.08	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	2.27	1.59	0.91	1.81	0.45	0.00	0.91	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	2.29	1.31	0.82	2.29	0.00	0.00	0.16	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	9.30	7.84	1.82	1.28	0.73	0.00	0.73	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	1.06	1.59	0.53	1.06	0.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	4.20	0.00	0.60	0.60	0.00	0.00	0.60	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	10.17	4.27	1.97	5.58	0.98	0.00	1.31	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	3.09	1.14	0.16	0.81	0.33	0.00	0.33	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	15.17	10.76	1.76	2.65	0.53	0.00	0.35	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	0.70	1.41	0.70	0.70	0.70	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	0.92	1.38	0.00	1.84	0.00	0.00	1.38	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	2.25	4.82	0.32	0.96	0.00	0.00	0.32	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	6.55	6.55	3.45	2.76	1.38	0.00	2.41	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	80.91	40.46	15.17	15.17	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	13.37	9.80	2.45	3.34	0.89	0.00	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	2.54	1.27	0.85	0.42	0.00	0.00	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	3.32	1.66	0.95	2.85	0.47	0.00	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	3.00	0.43	1.29	2.15	0.43	0.00	0.00	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	99.31	45.14	18.06	0.00	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	2.00	3.67	1.00	2.00	0.00	0.00	0.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	10.37	7.21	0.45	2.71	0.45	0.00	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	3.57	2.38	1.98	1.19	0.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	4.64	1.86	0.93	0.00	0.00	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	3.41	4.16	1.51	2.27	0.38	0.00	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	1.63	2.61	0.65	0.98	0.33	0.00	0.98	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	3.05	3.05	0.00	1.74	0.00	0.00	0.87	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	14.02	10.85	1.36	1.81	1.36	0.00	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	4.41	0.88	0.88	0.00	1.76	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	1.33	0.66	1.33	1.99	0.66	0.00	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	2.48	3.47	0.00	0.00	0.50	0.00	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	3.06	0.77	0.00	2.30	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	6.35	7.56	0.91	5.75	0.60	0.00	0.60	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	12.60	6.85	1.11	1.55	1.33	0.00	0.66	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	3.39	0.00	0.00	1.36	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	45.99	35.77	20.44	10.22	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	1.83	3.05	0.00	1.22	0.61	0.00	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	2.20	0.94	0.31	1.57	0.00	0.00	0.63	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	3.63	2.12	0.00	0.30	0.00	0.00	0.91	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	0.79	1.58	0.00	2.37	0.00	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	13.60	9.07	6.80	3.40	0.00	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	50.58	15.17	5.06	5.06	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	11.30	4.84	8.82	2.98	4.60	0.00	0.99	0.25
Myoblast, donor2	11322-117D8	13.43	10.16	4.03	3.64	1.15	0.00	0.58	0.19
Myoblast, donor3	11398-118D3	11.60	5.89	7.74	3.03	3.36	0.00	0.17	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	12.99	5.25	0.00	4.52	0.15	0.15	0.29	0.88
Natural Killer Cells, donor1	11230-116C6	35.98	12.92	27.98	16.61	7.38	0.00	0.31	0.92
Natural Killer Cells, donor2	11311-117C6	26.84	8.14	15.68	17.49	3.92	0.00	1.51	2.11
Natural Killer Cells, donor3	11387-118C1	33.68	11.78	18.59	21.35	4.60	0.00	1.10	0.92
Neural stem cells, donor1	11275-116H6	29.04	9.80	21.41	6.17	13.43	0.00	1.09	0.36
Neural stem cells, donor2	11352-117H2	30.81	13.48	26.96	3.85	19.26	1.93	3.85	0.00
Neurons, donor1	11494-119E9	17.07	13.65	7.97	6.83	6.83	0.00	1.14	0.00
Neurons, donor2	11574-120E8	12.99	9.91	14.97	5.94	5.28	0.00	0.66	0.22
Neurons, donor3	11655-122E8	13.15	2.47	14.80	6.58	4.11	0.00	0.82	0.82
Neutrophils, donor1	11233-116C9	41.76	20.42	0.00	9.28	0.00	0.00	1.86	0.00
Neutrophils, donor2	11314-117C9	31.89	34.79	0.00	11.60	2.90	0.00	17.39	0.00
Neutrophils, donor3	11390-118C4	62.31	33.60	0.00	20.77	0.00	0.00	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	14.13	13.42	4.04	3.09	1.90	0.00	0.71	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	4.23	3.91	1.63	0.98	1.30	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	7.02	4.41	0.60	0.80	1.00	0.00	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	4.96	3.44	1.79	1.24	0.69	0.00	0.83	0.00
Olfactory epithelial cells, donor2	11934-125I8	8.25	3.18	3.04	1.74	1.01	0.00	1.01	0.00
Olfactory epithelial cells, donor3	11935-125I9	5.45	2.95	2.04	1.36	0.45	0.00	0.45	0.23
Olfactory epithelial cells, donor4	11936-126A1	11.88	7.21	1.66	1.85	0.97	0.00	0.78	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	15.05	3.01	3.01	0.60	2.41	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	6.81	6.38	2.98	1.06	0.85	0.00	0.00	0.43
Osteoblast - differentiated, donor2	11353-117H3	5.72	4.57	0.00	1.14	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	4.97	2.48	0.62	0.62	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	5.08	2.54	2.54	1.17	0.98	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	15.45	7.02	6.32	4.21	2.11	0.00	0.70	0.00
Osteoblast, donor3	11426-118G4	9.95	4.98	2.84	2.31	0.89	0.00	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	8.17	6.49	5.90	3.20	2.44	0.00	0.25	0.17
Pericytes, donor1	11491-119E6	3.34	2.78	0.33	0.78	0.22	0.00	0.00	0.11
Pericytes, donor2	11571-120E5	3.62	2.04	0.23	1.58	0.45	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	3.66	1.83	0.81	1.22	0.61	0.00	0.20	0.00
Perineurial Cells, donor1	11499-119F5	12.66	7.01	5.65	2.71	2.60	0.00	0.11	0.23
Perineurial Cells, donor2	11579-120F4	11.13	7.08	5.06	2.67	1.47	0.00	0.28	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	41.44	22.31	14.66	13.07	3.51	0.00	0.00	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	25.71	17.87	9.55	8.57	1.47	0.00	0.24	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	28.60	14.37	4.53	12.94	0.65	0.00	0.52	0.39
Placental Epithelial Cells, donor1	11278-116H9	6.70	4.30	1.20	2.87	0.72	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	5.54	6.65	1.11	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	3.93	2.75	1.37	1.77	0.79	0.00	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	2.53	1.27	0.32	0.95	0.00	0.00	0.95	0.00
Preadipocyte - breast, donor1	11467-119B9	6.38	3.56	3.00	1.50	0.94	0.00	0.38	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	24.41	11.75	4.31	3.79	2.09	0.00	0.52	0.26
Preadipocyte - breast, donor2	11328-117E5	8.33	5.85	1.58	0.90	0.68	0.00	0.23	0.23
Preadipocyte - omental, donor1	11468-119C1	12.57	5.33	4.05	1.39	1.17	0.00	0.11	0.64
Preadipocyte - omental, donor2	11329-117E6	9.60	5.24	3.93	2.18	0.44	0.00	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	13.90	6.02	3.29	1.43	1.00	0.00	1.58	0.14
Preadipocyte - perirenal, donor1	11469-119C2	6.89	2.95	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	4.61	3.07	4.61	0.92	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	8.85	9.39	4.07	2.83	2.12	0.00	0.71	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	9.71	4.60	3.07	1.70	0.68	0.00	0.34	0.17
Preadipocyte - visceral, donor1	11280-116I2	14.53	7.82	9.04	1.21	3.63	0.09	0.28	0.19
Preadipocyte - visceral, donor2	11357-117H7	9.66	6.90	3.22	0.92	1.38	0.00	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	7.94	5.22	3.45	1.15	1.15	0.00	0.10	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	25.34	8.15	1.96	6.94	1.06	4.98	1.06	1.06
Prostate Epithelial Cells, donor2	11331-117E8	9.34	4.74	2.84	1.49	2.44	0.00	0.68	0.14
Prostate Epithelial Cells, donor3	11404-118D9	11.51	6.80	0.80	3.74	0.55	0.06	0.18	0.06
Prostate Stromal Cells, donor1	11254-116F3	7.86	6.04	5.92	2.28	3.08	0.00	0.23	0.11
Prostate Stromal Cells, donor2	11332-117E9	8.43	6.99	4.66	2.87	2.15	0.18	0.90	0.18
Prostate Stromal Cells, donor3	11405-118E1	7.20	6.57	1.25	2.71	1.25	0.00	0.31	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	3.28	1.82	0.00	0.73	0.00	0.00	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	6.86	3.81	4.23	2.01	2.91	0.00	0.21	0.00
Renal Epithelial Cells, donor1	11517-119H5	3.04	2.03	0.51	0.00	0.51	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	3.56	2.13	0.71	2.13	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	10.16	5.72	4.23	1.48	2.75	0.00	0.42	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.72	0.68	0.00	0.68	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	4.04	1.48	0.67	1.62	0.13	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	14.65	5.11	3.11	2.66	0.89	0.00	0.22	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	3.99	2.00	0.00	1.33	0.00	0.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	5.50	2.86	1.76	0.88	1.10	0.00	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	3.13	4.39	0.63	1.25	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	0.83	1.66	0.28	1.39	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	5.64	3.49	0.54	0.81	0.54	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	0.84	2.53	0.42	0.84	0.84	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	2.70	0.96	1.54	1.35	0.58	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	8.30	3.11	9.07	1.56	7.26	0.52	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	5.97	2.84	0.00	0.57	1.14	0.00	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	2.06	0.00	0.00	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	10.79	3.26	3.01	1.25	2.51	0.00	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	28.87	11.89	3.61	8.69	1.20	3.61	0.94	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	10.72	8.04	3.57	1.79	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	15.96	5.50	5.50	8.81	4.95	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	26.10	14.50	2.90	6.96	2.32	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	31.73	12.74	2.47	5.33	1.95	0.00	0.00	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	18.87	7.85	2.09	5.56	0.99	0.10	0.30	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	21.64	10.48	3.01	9.82	1.90	0.00	0.22	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	26.55	14.39	2.73	9.43	2.23	0.00	0.87	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	15.97	6.64	1.52	4.55	1.28	0.00	0.58	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	28.20	14.10	3.47	7.17	1.16	0.00	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	18.35	8.76	1.92	5.75	1.10	0.00	0.55	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	17.85	10.29	1.82	6.81	0.30	0.00	0.76	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	20.79	11.65	3.40	6.27	1.61	0.00	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	17.50	8.32	1.00	6.74	1.00	0.00	1.43	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	17.28	10.73	2.47	6.55	1.50	0.00	0.64	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	16.37	12.17	3.54	5.75	0.44	0.00	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	18.35	8.22	1.15	7.26	0.57	0.00	0.76	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	20.12	10.81	1.96	8.38	1.58	0.00	0.37	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	20.29	14.47	4.13	6.20	1.50	0.00	0.56	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	22.03	9.29	1.33	9.29	0.27	0.00	0.40	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	20.05	11.97	2.63	7.40	1.17	0.00	0.78	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	18.90	9.74	2.86	6.11	1.91	0.00	1.34	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	20.08	9.40	1.39	5.34	1.39	0.00	0.53	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	22.99	11.77	2.24	7.01	1.96	0.00	2.24	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	26.32	15.72	2.39	8.72	1.03	0.00	0.51	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	15.50	8.75	1.46	6.75	0.55	0.00	0.55	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	19.38	9.81	1.84	5.64	1.23	0.00	0.49	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	24.58	9.81	2.01	9.67	0.81	0.00	0.40	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	13.68	4.25	0.47	3.77	1.65	0.00	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	17.06	10.12	2.38	5.95	1.39	0.00	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	23.15	9.12	3.04	7.25	1.40	0.00	0.70	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	16.38	7.46	1.04	6.43	1.24	0.00	0.41	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	18.80	10.62	1.77	6.19	1.55	0.00	0.22	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	19.22	12.32	1.25	6.68	0.84	0.00	0.63	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	16.15	11.17	0.67	8.88	1.08	0.13	0.40	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	21.80	11.75	3.24	8.34	0.68	0.00	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	20.05	8.87	2.51	9.64	1.16	0.00	0.19	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	11.52	8.94	1.38	6.88	1.03	0.17	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	19.34	13.58	2.06	10.70	0.96	0.14	0.55	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	14.61	14.78	2.63	8.04	1.64	0.00	0.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	18.24	9.20	0.68	7.84	0.85	0.17	1.02	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	15.68	11.10	2.22	6.21	0.89	0.00	0.30	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	16.79	13.59	1.33	9.06	0.27	0.00	0.27	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	19.50	10.23	0.97	5.53	1.11	0.00	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	11.67	8.81	0.24	5.00	0.24	0.00	0.00	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	26.60	14.51	1.61	10.48	1.41	0.00	0.81	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	13.75	8.00	0.85	4.61	0.66	0.09	0.66	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	18.87	8.38	2.45	7.34	1.40	0.00	1.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	12.09	10.58	1.21	4.53	3.02	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	11.63	8.20	0.86	4.04	0.61	0.00	0.61	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	50.94	20.09	7.71	12.66	3.35	0.00	0.29	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	16.43	10.34	1.83	4.87	0.00	0.00	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	16.28	5.12	0.30	3.92	0.90	0.00	0.90	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	19.68	8.14	1.13	6.79	0.45	0.00	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	20.97	12.88	1.20	6.29	0.90	0.00	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	21.02	8.15	2.60	4.13	1.53	0.00	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	23.48	9.39	2.13	9.61	1.28	0.00	0.21	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	25.84	12.62	1.20	10.22	1.20	0.00	0.60	0.60
Schwann Cells, donor1	11498-119F4	2.07	1.88	0.56	2.07	0.38	0.00	0.19	0.19
Schwann Cells, donor2	11578-120F3	0.00	3.40	10.21	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	7.23	5.04	5.48	2.41	2.63	0.00	0.44	0.22
Sebocyte, donor1	11220-116B5	17.53	12.05	3.83	3.29	1.10	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	6.43	2.76	4.14	3.22	3.22	0.00	1.38	0.00
Sebocyte, donor3	11378-118B1	6.80	4.12	1.65	1.86	1.24	0.00	0.41	0.21
Sertoli Cells, donor1	11255-116F4	29.82	8.28	4.97	3.31	1.66	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	5.65	5.65	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	7.92	5.98	3.96	1.67	1.50	0.00	0.35	0.09
Skeletal Muscle Cells, donor2	11358-117H8	5.06	2.17	0.00	2.17	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	5.02	8.36	1.67	1.67	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	13.67	8.95	3.30	2.36	3.61	0.00	0.47	0.16
Skeletal Muscle Cells, donor5	11455-119A6	8.77	5.50	2.08	3.27	2.23	0.00	0.59	0.00
Skeletal Muscle Cells, donor6	11459-119B1	15.24	8.62	3.85	2.62	3.69	0.00	0.92	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	16.76	17.39	8.82	2.77	6.30	0.00	0.50	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	13.41	10.99	4.00	3.85	2.71	0.00	1.14	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	19.05	10.32	6.45	4.76	2.78	0.30	0.60	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	7.92	6.49	5.31	2.78	2.70	0.00	0.42	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	5.07	2.90	2.17	0.72	0.00	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	3.44	3.16	0.69	2.06	0.69	0.00	0.14	0.28
Skin - palm, donor1	10286-104F7	45.66	40.29	5.37	5.37	0.00	0.00	2.69	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	3.75	1.44	0.72	1.15	0.29	0.00	1.01	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	61.34	18.81	10.63	13.90	9.00	0.00	5.73	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	3.12	1.56	0.78	1.43	0.39	0.13	0.52	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	9.45	5.42	3.34	1.11	1.53	0.00	0.28	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	9.85	3.80	1.83	2.39	0.98	0.00	0.28	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	66.18	28.33	20.30	19.24	6.98	0.42	0.85	1.06
Small Airway Epithelial Cells, donor3	11406-118E2	14.62	6.37	1.12	2.47	0.67	0.00	0.37	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	3.39	2.47	0.62	0.93	0.62	0.00	0.93	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	18.90	8.89	2.89	3.11	2.00	0.00	0.44	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	12.34	4.70	2.94	1.18	0.59	0.00	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	7.73	6.41	4.86	2.21	1.55	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	5.91	3.54	3.54	0.79	0.79	0.00	0.39	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	16.22	5.41	3.09	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	5.00	5.00	1.00	4.00	1.00	0.00	3.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	8.52	4.66	2.40	2.13	0.13	0.00	0.13	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	7.76	7.31	4.21	0.66	0.66	0.00	0.89	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	11.78	6.66	2.18	1.66	0.77	0.00	0.26	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	11.72	8.14	8.14	1.63	3.58	0.00	0.65	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	10.93	7.68	5.91	2.66	2.95	0.00	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	12.81	6.26	3.99	2.85	1.71	0.00	0.28	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1.46	0.49	0.33	0.81	0.33	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	7.61	6.09	2.44	1.83	0.61	0.00	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	11.11	5.81	3.79	1.77	1.01	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	30.60	48.97	0.00	12.24	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	3.34	1.43	0.00	0.95	0.95	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	8.70	7.52	6.34	3.39	3.54	0.15	0.44	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	12.48	8.82	3.66	3.23	3.01	0.00	0.86	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	11.65	10.39	4.30	3.88	2.73	0.10	0.42	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	8.35	3.25	1.55	0.62	1.24	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	1.08	1.08	3.23	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	5.98	3.59	1.79	0.30	0.00	0.00	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	4.10	2.05	0.34	1.02	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	8.95	8.95	3.69	2.51	2.91	0.00	0.63	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	9.66	5.54	6.14	1.71	4.23	0.00	0.40	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	12.74	7.28	7.74	2.28	1.14	0.00	0.46	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	4.23	1.21	1.21	1.21	1.21	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	15.37	7.42	7.42	4.50	3.71	0.00	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	9.99	6.79	3.33	2.53	3.60	0.00	0.40	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	9.39	8.51	4.13	2.00	1.75	0.13	0.88	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	5.33	1.52	3.80	1.01	1.01	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	7.39	7.09	9.35	1.21	1.51	0.00	0.45	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	10.50	1.50	4.50	0.75	2.25	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	23.26	25.84	2.58	2.58	3.88	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	13.02	5.58	1.40	0.93	0.00	0.00	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	4.54	3.03	2.52	0.50	0.50	0.00	1.01	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	3.13	4.70	2.51	0.94	0.31	0.00	0.63	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	0.88	1.18	0.29	0.00	0.00	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	9.50	6.58	6.83	2.25	3.00	0.17	0.00	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	8.41	8.88	3.74	1.87	1.40	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	6.48	2.16	2.59	0.58	0.72	0.00	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	5.61	3.31	2.80	2.04	0.51	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	2.26	1.88	1.32	0.75	0.38	0.00	0.19	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	8.38	6.43	9.36	2.66	5.03	0.42	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	7.71	5.03	4.94	1.42	1.76	0.00	0.17	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	0.48	0.95	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	5.14	0.49	1.71	0.73	0.73	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	5.74	3.54	2.21	1.99	3.54	0.00	0.66	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	5.56	4.10	7.61	2.05	2.63	0.00	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	8.36	8.36	0.58	1.94	0.78	0.00	0.39	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	8.20	2.38	2.91	1.59	1.59	0.26	1.85	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	4.84	2.60	4.09	2.60	1.49	0.00	1.12	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	9.70	5.03	5.03	1.80	2.87	0.36	1.80	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	7.95	4.54	3.41	3.12	1.99	0.00	0.85	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	5.91	3.94	1.18	0.39	1.18	0.00	1.18	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	9.14	4.83	1.52	2.54	1.78	0.25	1.78	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	8.79	5.19	1.60	2.40	0.40	0.00	2.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	5.43	4.60	2.09	1.25	1.67	0.00	2.93	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	4.58	4.13	0.92	2.75	0.46	0.00	2.29	0.46
Synoviocyte, donor1	11291-117A4	10.60	3.70	5.72	1.18	0.67	0.00	0.00	0.17
Synoviocyte, donor2	11368-117I9	6.20	6.03	3.18	0.84	0.34	0.00	0.17	0.00
Synoviocyte, donor3	11440-118H9	3.80	5.36	1.34	0.67	0.22	0.00	0.67	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	4.29	1.79	2.14	2.86	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	1.98	0.00	0.00	0.00	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	5.56	2.55	1.16	1.62	1.16	0.00	0.00	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	7.17	2.87	1.94	0.86	0.86	0.00	0.07	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	3.09	3.09	0.77	0.77	0.77	0.00	0.39	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	4.58	1.15	0.00	1.15	0.57	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	28.42	16.85	2.83	8.61	0.74	3.20	0.37	0.37
Urethra, donor2	10319-105A4	25.18	26.98	1.80	12.59	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	2.39	0.53	0.53	0.53	0.27	0.00	0.27	0.00
Urothelial Cells, donor2	11600-120H7	0.80	2.00	0.40	0.80	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	5.04	1.83	0.23	0.92	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	13.82	8.92	4.01	0.45	0.89	0.00	0.67	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	15.13	9.79	3.56	6.23	0.00	0.00	1.78	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	27.16	20.01	2.86	7.15	1.43	0.00	5.72	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	10.27	17.80	1.37	7.53	0.00	0.00	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	16.18	11.71	4.48	7.23	0.00	0.00	1.03	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	8.72	14.53	2.32	5.23	1.16	0.00	2.32	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	13.54	10.41	2.08	1.04	0.00	0.00	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	14.68	12.85	0.92	5.51	0.00	0.00	0.92	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	9.13	14.61	1.83	6.39	0.00	0.00	2.74	0.91
Wilms' tumor cell line:G-401	10809-111A8	16.65	10.98	3.45	5.43	1.60	0.12	0.37	0.99
Wilms' tumor cell line:HFWT	10597-108E3	31.68	29.04	0.00	10.56	0.00	0.00	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	11.73	9.78	1.40	5.59	1.68	0.00	0.28	0.84
achilles tendon, donor2	10292-104G4	10.33	12.40	8.27	2.07	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	18.10	5.10	2.04	14.02	0.51	0.00	1.02	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	26.93	15.56	8.36	7.66	1.16	0.00	0.70	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	51.28	23.74	7.48	15.31	3.68	0.00	0.59	2.73
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	14.97	11.70	13.06	7.35	6.53	0.00	2.45	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	12.09	4.50	3.65	2.81	1.41	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	21.78	11.84	10.15	8.67	3.17	0.00	0.63	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	20.96	11.43	11.98	8.98	3.27	0.27	1.36	1.63
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	16.30	12.34	5.73	6.17	3.53	0.00	0.44	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	20.42	16.33	6.13	8.98	1.63	0.00	1.23	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	22.13	15.92	5.44	11.65	1.94	0.00	1.55	3.11
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	11.41	9.57	2.39	7.73	1.47	0.00	0.37	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	62.41	46.81	19.50	27.30	0.00	0.00	3.90	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	19.98	14.18	22.54	4.18	7.20	0.46	1.39	2.09
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	27.44	21.49	7.77	10.61	2.07	0.00	1.55	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	26.01	20.75	4.68	12.27	3.80	0.00	2.63	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	14.41	18.59	2.32	8.37	1.39	0.00	0.00	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	17.68	7.81	1.65	7.81	0.41	0.00	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	5.83	5.53	0.92	8.29	0.00	0.31	0.61	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	8.11	12.37	10.24	8.11	2.56	0.85	0.43	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	13.04	18.80	5.16	9.10	2.73	0.91	0.30	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	13.72	14.92	7.70	10.83	2.17	0.96	0.24	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	14.70	6.24	1.78	5.35	1.11	0.00	0.89	0.89
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	25.35	12.67	4.67	6.00	3.67	1.00	0.67	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	59.46	31.59	9.29	9.29	5.57	0.00	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	25.24	10.55	19.21	7.91	4.14	1.13	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	28.35	22.24	12.21	9.59	2.18	0.00	0.44	3.05
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	24.37	11.25	16.87	5.62	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	19.55	9.42	3.30	3.30	0.94	5.89	0.24	0.24
adipose tissue, adult, pool1	10010-101C1	22.18	15.67	6.36	6.98	2.17	0.00	0.47	0.16
adipose, donor1	10184-103D4	26.39	12.31	9.38	20.52	11.73	0.00	4.10	0.59
adipose, donor2	10185-103D5	2.84	5.68	6.89	8.52	4.06	0.00	0.81	0.00
adipose, donor3	10186-103D6	15.25	10.89	4.90	11.71	3.00	0.00	0.54	1.09
adipose, donor4	10187-103D7	43.34	33.80	4.33	9.53	6.07	0.00	1.73	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	7.26	12.63	3.63	2.84	1.89	0.00	0.16	0.16
adrenal gland, adult, pool1	10081-102A9	3.64	3.64	3.64	7.28	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	9.61	8.14	0.00	7.74	0.53	0.00	0.27	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	6.07	5.72	1.43	2.14	0.00	0.00	0.36	0.36
amniotic membrane cells, donor1	12235-129G3	17.39	6.03	2.09	2.09	0.23	0.00	0.93	0.00
amniotic membrane cells, donor2	12236-129G4	27.05	11.50	2.03	3.72	1.35	0.00	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	20.62	19.15	2.65	3.24	2.36	0.00	1.47	0.00
amygdala - adult, donor10196	10167-103B5	22.53	11.86	17.79	7.11	8.30	0.00	1.19	0.00
amygdala, adult, donor10252	10151-102I7	31.43	37.71	12.37	28.18	8.72	0.20	0.81	0.81
amygdala, newborn, donor10223	10360-105E9	7.75	7.75	7.75	8.39	5.81	0.00	0.65	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	17.95	8.66	2.04	3.82	1.02	0.00	0.38	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	15.22	7.50	0.00	7.06	0.00	0.00	0.00	0.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	27.73	45.76	0.67	5.34	1.00	0.00	1.34	0.00
aorta, adult, pool1	10052-101G7	13.73	11.57	4.31	4.51	0.78	0.00	0.78	0.00
appendix, adult	10189-103D9	35.32	36.09	3.10	17.85	1.16	0.00	0.39	1.94
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	23.39	15.13	9.63	8.25	4.82	0.34	0.69	1.03
artery, adult	10190-103E1	19.02	13.59	6.79	1.36	1.36	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	22.60	7.97	11.01	2.61	1.88	0.14	0.43	0.14
b cell line:RPMI1788	10427-106D4	17.84	9.67	4.31	10.41	5.06	0.00	0.15	0.89
basal cell carcinoma cell line:TE 354.T	10702-109G9	13.87	5.55	4.72	1.39	0.28	0.00	0.55	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	16.77	8.93	6.55	2.48	2.18	0.00	0.00	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	22.76	4.52	3.35	3.68	1.17	6.53	1.00	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	11.74	8.39	2.80	3.36	1.68	0.00	0.56	0.56
bladder, adult, pool1	10011-101C2	19.34	22.81	2.93	5.32	1.20	0.00	0.54	0.22
blood, adult, pool1	10053-101G8	2.21	2.21	0.00	11.07	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	23.12	10.28	5.14	1.71	1.71	0.00	0.00	0.86
bone marrow, adult	10192-103E3	14.85	16.87	7.42	1.35	4.72	0.00	2.02	0.00
brain, adult, donor1	10084-102B3	7.18	15.38	2.05	1.03	4.10	0.00	0.00	1.03
brain, adult, pool1	10012-101C3	22.27	14.59	13.81	8.24	5.57	0.00	0.67	0.33
brain, fetal, pool1	10085-102B4	5.34	8.01	5.34	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	21.80	16.52	1.65	5.95	1.32	0.00	0.99	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	24.71	14.60	9.11	4.62	2.50	0.00	0.50	0.25
breast, adult, donor1	10080-102A8	5.68	1.89	1.26	7.58	0.63	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	6.99	8.51	3.30	2.41	0.89	0.00	0.64	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	29.99	13.30	5.57	3.09	2.47	0.00	1.24	1.55
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	4.83	8.06	2.30	3.68	2.30	0.00	0.92	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	18.16	4.60	2.66	3.15	1.21	0.48	0.73	0.24
carcinoid cell line:NCI-H1770	10703-109H1	16.46	11.28	4.23	5.64	2.35	0.00	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	35.55	8.20	2.52	2.30	2.08	3.50	0.22	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	17.11	9.19	7.92	3.80	3.80	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	16.50	17.30	7.72	7.19	2.93	0.00	0.80	0.00
caudate nucleus - adult, donor10196	10177-103C6	21.88	16.12	13.82	9.21	2.30	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	31.12	35.47	7.20	23.26	7.53	0.00	1.17	0.84
caudate nucleus, adult, donor10258	10379-105H1	12.99	11.46	5.35	6.11	4.58	0.00	2.29	0.00
caudate nucleus, newborn, donor10223	10354-105E3	7.69	10.25	12.09	9.16	11.72	0.37	0.37	0.73
cerebellum - adult, donor10196	10173-103C2	72.83	52.44	17.48	2.91	5.83	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	83.27	72.17	13.24	51.67	6.83	0.00	1.92	0.85
cerebellum, adult, pool1	10083-102B2	18.97	13.80	5.86	6.21	3.45	0.34	1.03	0.00
cerebellum, newborn, donor10223	10357-105E6	29.89	31.55	16.61	22.42	8.30	0.00	0.83	0.83
cerebral meninges, adult	10188-103D8	15.38	13.87	9.08	8.32	2.77	0.00	1.26	0.25
cerebrospinal fluid, donor2	10294-104G6	5.85	10.96	2.92	4.39	0.73	0.00	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	13.08	8.91	3.16	2.59	1.01	0.00	0.43	0.43
cervical cancer cell line:ME-180	10553-107I4	15.58	5.47	2.82	1.66	1.99	0.00	0.17	0.00
cervix, adult, pool1	10013-101C4	22.15	29.19	5.98	5.46	2.62	0.00	0.63	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	10.73	4.04	1.95	1.53	0.70	0.00	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	16.98	9.14	2.61	6.53	0.00	0.00	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	24.36	14.66	0.00	7.21	0.25	0.00	0.75	0.50
choriocarcinoma cell line:SCH	10785-110H2	15.03	10.23	0.00	3.82	0.00	0.25	0.37	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	16.60	14.23	0.47	5.22	0.95	0.47	0.24	0.71
chorionic membrane cells, donor1	12238-129G6	14.53	7.12	2.28	3.70	0.00	0.00	0.85	0.00
chorionic membrane cells, donor2	12239-129G7	18.79	9.45	2.59	4.67	1.09	0.00	0.80	0.30
chorionic membrane cells, donor3	12240-129G8	15.39	12.64	1.10	3.85	0.55	0.00	1.65	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	8.08	6.06	3.03	3.03	2.02	0.00	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	14.60	8.45	7.49	4.61	3.46	0.00	0.58	1.34
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	11.40	6.12	13.09	4.86	3.38	0.21	0.84	2.75
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	13.35	17.46	22.08	11.56	7.70	3.85	0.26	1.03
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	20.32	15.72	16.69	9.68	5.81	4.11	0.24	1.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	20.97	15.07	23.21	11.20	9.37	3.46	0.41	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	20.91	16.20	22.67	7.95	12.07	2.94	1.18	2.06
chronic myelogenous leukemia cell line:KU812	10409-106B4	37.27	21.63	52.39	8.86	11.73	0.52	0.52	1.30
clear cell carcinoma cell line:JHOC-5	10638-108I8	8.46	7.77	2.29	1.14	1.37	0.00	0.69	0.69
clear cell carcinoma cell line:TEN	10636-108I6	13.71	7.46	1.21	2.78	0.69	0.35	0.69	0.35
colon carcinoma cell line:CACO-2	10513-107D9	18.12	6.96	1.28	4.76	1.46	14.28	0.55	0.73
colon carcinoma cell line:COLO-320	10420-106C6	58.53	20.90	19.38	4.94	22.04	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	11.90	14.28	1.19	4.76	0.00	0.00	2.38	1.19
colon, adult, pool1	10014-101C5	37.84	18.80	2.82	5.76	1.06	1.06	0.71	0.59
colon, fetal, donor1	10070-101I7	8.65	11.74	1.24	6.80	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	261.26	100.84	0.00	36.67	0.00	0.00	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	27.62	10.20	26.35	11.05	9.35	0.00	0.85	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	12.98	6.04	5.43	6.34	2.11	0.00	0.15	0.91
cord blood derived cell line:COBL-a untreated	10449-106F8	16.50	8.04	3.67	6.63	1.83	0.00	0.28	0.56
corpus callosum, adult, pool1	10042-101F6	26.09	33.06	13.27	13.49	7.85	0.00	0.88	0.22
cruciate ligament, donor2	10295-104G7	21.88	17.83	4.86	5.67	3.24	0.00	3.24	0.81
diaphragm, fetal, donor1	10069-101I6	13.64	8.83	4.82	8.03	0.80	0.00	1.61	0.00
diencephalon, adult	10193-103E4	11.28	16.56	8.64	9.60	4.32	0.00	0.48	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	19.06	8.73	0.92	6.89	0.46	0.00	1.61	1.15
ductal cell carcinoma cell line:KLM-1	10438-106E6	22.31	14.10	1.54	2.82	2.56	0.00	0.51	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	9.63	4.81	3.61	0.48	4.57	0.00	0.72	0.24
ductus deferens, adult	10196-103E7	27.91	16.45	7.97	9.97	2.49	0.00	1.00	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	5.76	7.20	4.32	10.08	2.88	0.00	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	33.10	33.10	9.56	9.56	2.94	0.00	3.68	1.47
dura mater, adult, donor1	10041-101F5	29.73	28.91	11.64	3.96	1.90	0.08	0.33	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	26.87	4.66	12.66	7.99	6.44	0.44	0.89	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	12.04	6.16	5.30	6.88	4.44	0.00	0.29	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	22.20	8.63	0.62	2.47	0.62	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	9.99	11.50	0.61	3.94	0.91	0.00	0.30	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	25.93	10.19	1.54	4.63	1.54	0.00	0.62	1.23
embryonic pancreas cell line:2C6	10603-108E9	30.21	17.08	0.00	3.94	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	11.40	5.36	4.36	1.68	1.34	0.00	0.34	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	14.86	10.15	15.59	3.81	3.81	0.00	1.99	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	16.40	8.84	0.80	2.89	0.80	0.00	1.45	0.00
epidermoid carcinoma cell line:A431	10426-106D3	38.02	12.89	2.11	2.33	1.89	0.00	0.33	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	20.46	12.43	3.19	3.96	0.99	0.00	0.22	0.77
epididymis, adult	10197-103E8	21.14	22.40	14.23	6.70	5.02	0.00	0.00	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	6.39	3.90	4.97	1.60	1.24	0.18	0.18	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	9.44	6.29	1.57	0.79	0.79	0.00	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	12.06	11.14	2.49	11.14	0.92	0.26	0.52	0.66
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	10.24	9.05	1.57	8.56	0.98	0.10	0.10	0.59
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	10.98	11.54	2.35	10.53	1.12	0.00	0.34	0.22
esophagus, adult, pool1	10015-101C6	24.74	18.05	3.72	3.93	1.49	0.00	0.21	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	38.45	28.30	27.93	12.77	3.63	0.00	0.50	0.38
eye - muscle inferior rectus, donor1	10272-104E2	45.88	12.07	4.83	9.66	2.41	0.00	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	16.83	8.42	4.21	2.10	4.21	0.00	2.10	2.10
eye - muscle medial, donor2	10299-104H2	29.76	22.32	5.95	11.91	1.49	0.00	0.00	2.98
eye - muscle superior, donor2	10297-104G9	25.22	17.20	8.03	6.88	0.00	0.00	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	17.49	17.49	4.37	5.83	2.91	0.00	2.91	0.00
eye, fetal, donor1	10054-101G9	13.47	12.97	10.17	3.81	18.56	0.25	0.51	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	13.08	6.41	5.51	2.69	1.41	0.13	0.51	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	10.68	7.12	4.75	4.27	1.19	0.00	0.47	0.47
frontal lobe, adult, pool1	10040-101F4	30.40	28.80	21.95	9.19	12.85	0.00	0.38	0.75
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	19.52	7.81	3.60	4.20	0.00	0.00	1.80	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	11.06	10.06	10.52	1.37	2.93	0.09	0.00	0.18
gall bladder, adult	10198-103E9	25.11	19.80	4.83	7.48	2.17	0.00	0.00	0.24
gamma delta positive T cells, donor1	11937-126A2	11.27	8.59	5.91	13.96	1.07	0.00	1.07	0.00
gamma delta positive T cells, donor2	11938-126A3	9.71	8.96	8.96	20.17	2.24	0.00	1.12	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	19.01	6.34	2.75	6.13	2.32	0.00	1.06	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	14.31	7.35	2.51	3.67	0.39	0.00	0.39	0.00
gastric cancer cell line:AZ521	10549-107H9	28.36	11.15	2.62	5.08	2.30	0.00	0.33	0.49
gastric cancer cell line:GSS	10560-108A2	5.49	10.98	1.83	0.92	1.83	0.92	0.92	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	39.29	13.25	3.66	7.08	2.97	0.00	1.60	1.14
giant cell carcinoma cell line:LU65	10487-107B1	12.51	4.70	7.92	3.33	1.61	0.00	0.46	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	20.43	13.16	3.50	2.94	4.48	0.00	0.14	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	21.20	13.47	5.24	3.74	2.00	0.00	0.25	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	8.55	3.48	2.43	0.63	2.22	0.00	0.32	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	6.88	3.51	3.37	0.56	2.95	0.14	0.14	0.00
glioblastoma cell line:T98G	10485-107A8	15.12	5.52	1.32	2.21	2.10	0.00	0.66	0.11
glioma cell line:GI-1	10413-106B8	14.94	8.79	0.88	1.76	0.59	0.00	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	7.29	10.93	5.83	8.75	5.83	0.00	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	26.36	48.33	9.76	35.64	5.61	0.00	0.73	1.46
globus pallidus, adult, donor10258	10367-105F7	8.22	9.58	10.95	10.95	9.58	0.00	1.37	1.37
globus pallidus, newborn, donor10223	10364-105F4	7.99	11.72	6.93	10.13	4.80	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	210.45	92.99	4.89	41.60	2.45	0.00	0.00	9.79
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	10.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	0.00	10.45	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	18.56	8.96	4.16	0.96	2.24	0.00	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	16.99	7.35	0.46	1.38	0.46	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	15.55	7.77	0.00	2.74	0.46	0.00	1.83	0.46
hIPS +CCl2, biol_rep3	14385-156C2	9.66	5.15	0.00	3.86	0.00	0.64	1.29	0.00
hIPS, biol_rep1	14380-156B6	33.06	7.19	0.00	5.75	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	17.15	5.49	0.00	4.80	0.00	0.69	0.00	0.69
hIPS, biol_rep3	14382-156B8	13.24	13.24	6.62	7.72	6.62	0.00	0.00	2.21
hairy cell leukemia cell line:Mo	10712-109I1	7.76	7.76	5.46	11.21	2.87	0.00	1.44	0.00
heart - mitral valve, adult	10205-103F7	31.39	21.53	11.66	7.47	2.39	0.00	0.90	0.30
heart - pulmonic valve, adult	10206-103F8	32.16	28.76	8.37	6.28	1.83	0.00	0.52	0.52
heart - tricuspid valve, adult	10207-103F9	38.30	35.80	7.49	21.65	1.67	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	12.04	7.35	3.26	3.47	0.82	0.00	0.41	0.82
heart, adult, diseased, donor1	10051-101G6	17.88	8.52	4.68	3.41	0.85	0.00	0.85	0.43
heart, adult, pool1	10016-101C7	27.83	14.95	2.53	5.29	0.23	0.00	0.00	0.00
heart, fetal, pool1	10046-101G1	57.71	25.26	13.04	8.21	3.59	0.10	0.31	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	13.88	6.17	2.78	0.93	0.62	0.00	0.31	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	63.03	24.97	0.00	11.89	0.00	9.51	0.00	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	44.75	17.35	0.22	13.37	0.55	36.68	0.99	1.10
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	47.94	20.75	0.36	17.36	0.24	41.39	1.21	0.85
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	52.55	21.02	0.71	17.38	0.40	43.55	1.31	1.21
hepatoma cell line:Li-7	10484-107A7	15.13	5.45	1.67	2.78	1.00	0.11	0.33	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	13.97	6.93	1.51	6.03	0.40	0.00	0.70	0.20
hippocampus - adult, donor10196	10169-103B7	6.62	22.71	15.14	9.46	8.52	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	31.64	33.06	11.02	27.55	6.53	0.00	1.43	0.61
hippocampus, adult, donor10258	10374-105G5	16.93	13.44	4.48	9.46	1.49	0.00	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	5.64	6.34	7.75	6.70	5.64	0.00	0.70	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	17.70	10.38	0.00	6.71	0.61	0.00	2.44	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	14.14	9.82	0.20	8.25	0.59	0.00	1.96	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	20.82	12.95	0.25	6.35	0.25	0.00	0.76	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	12.41	7.33	0.00	16.92	2.26	0.00	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	14.20	13.17	0.26	14.20	3.36	0.00	1.03	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	19.36	11.39	1.52	10.25	1.52	0.00	1.90	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	15.47	10.22	8.17	14.31	8.17	0.00	0.88	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	13.57	14.43	7.11	12.06	9.05	0.43	2.15	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	13.76	10.01	5.42	13.35	10.01	0.00	0.42	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	17.52	11.84	9.23	9.95	8.76	0.00	0.95	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	15.75	9.32	8.04	10.93	3.54	0.00	0.80	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	26.93	4.04	9.43	6.73	5.39	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	17.21	7.82	0.16	6.26	0.16	0.00	0.94	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	15.23	9.83	0.00	8.35	0.49	0.98	2.95	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	9.60	7.85	1.75	9.60	0.00	0.00	1.75	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	15.85	11.26	2.10	19.28	2.86	0.00	1.15	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	20.06	6.11	1.74	12.65	2.18	0.00	1.74	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	10.49	9.50	3.00	16.49	3.50	1.00	2.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	9.98	10.36	10.93	6.97	9.80	0.00	0.75	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	9.09	9.55	7.73	5.91	8.64	0.00	1.36	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	4.39	7.83	8.46	6.26	6.26	0.00	0.94	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	11.59	4.74	11.10	6.04	4.74	0.16	0.82	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	11.32	4.64	9.00	4.64	4.64	0.29	1.16	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	9.27	5.38	10.76	8.97	3.59	0.00	0.60	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	12.75	9.05	0.37	6.65	0.18	0.37	0.55	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	14.83	8.56	0.00	9.98	0.00	0.29	0.86	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	16.74	7.76	0.41	10.21	0.41	0.82	1.22	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	12.32	11.97	1.76	10.21	4.58	0.00	1.41	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	14.25	6.97	2.22	10.14	5.38	0.32	2.22	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	16.34	6.96	1.82	8.17	4.24	0.61	3.03	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	9.83	7.76	10.86	5.17	5.69	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	7.31	8.63	10.63	5.98	4.65	0.00	1.99	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	15.14	6.67	10.00	6.93	6.93	0.26	1.03	2.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	13.04	10.23	8.18	4.35	5.62	0.00	2.05	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	8.33	4.54	6.82	8.33	0.76	0.00	0.00	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	13.78	3.70	11.09	8.40	3.36	0.34	1.01	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	14.73	11.11	0.24	7.73	0.24	0.00	0.48	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	9.80	7.13	0.45	8.02	0.00	0.00	0.45	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	14.15	7.32	0.00	11.22	0.00	0.00	1.46	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	17.11	12.22	0.31	14.06	4.58	0.00	1.22	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	100.85	52.05	16.27	32.53	32.53	0.00	19.52	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	19.19	13.90	0.33	13.24	8.94	0.00	1.65	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	18.06	8.76	4.38	9.30	7.66	0.00	1.09	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	11.22	9.77	5.79	8.69	9.05	0.00	0.72	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	11.74	9.96	8.54	10.32	7.47	0.00	1.42	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	10.74	5.97	7.16	3.58	7.16	1.19	2.39	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	22.89	12.19	18.01	8.67	8.40	0.00	0.95	0.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	11.05	3.50	7.00	8.08	3.23	0.00	0.54	0.81
immature langerhans cells, donor1	11904-125F5	23.97	11.87	16.71	2.18	3.63	0.00	0.73	0.24
immature langerhans cells, donor2	11905-125F6	40.40	15.84	11.88	1.58	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	31.23	32.65	20.54	9.94	11.83	0.00	0.38	0.85
keratoacanthoma cell line:HKA-1	10791-110H8	8.13	6.50	1.30	4.88	0.00	0.00	0.00	0.33
kidney, adult, pool1	10017-101C8	29.34	15.52	7.11	5.11	2.50	2.90	0.60	0.10
kidney, fetal, pool1	10045-101F9	35.37	20.37	4.95	7.07	1.77	0.21	0.21	0.35
large cell lung carcinoma cell line:IA-LM	10509-107D5	18.32	9.94	8.24	2.41	1.99	0.00	0.00	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	8.02	3.87	0.83	4.15	0.28	1.52	0.14	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	13.03	6.97	0.92	1.10	0.55	0.00	0.18	0.37
left atrium, adult, donor1	10079-102A7	2.72	5.45	5.99	2.72	0.54	0.00	0.54	0.00
left ventricle, adult, donor1	10078-102A6	5.56	2.53	0.51	2.02	0.00	0.00	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	18.33	10.40	4.92	3.83	1.92	0.00	0.55	0.00
leiomyoma cell line:10964C	10569-108B2	2.51	3.95	4.67	1.08	1.08	0.36	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	5.43	4.89	5.43	1.63	2.17	0.00	2.72	0.00
leiomyoma cell line:15425	10571-108B4	2.91	2.43	6.80	1.21	1.94	0.00	1.21	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	21.96	15.68	2.09	6.27	2.09	0.00	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	24.91	11.92	16.88	7.08	3.19	3.90	0.35	1.18
liposarcoma cell line:KMLS-1	10782-110G8	9.53	8.28	6.09	3.12	1.25	0.00	0.31	0.31
liposarcoma cell line:SW 872	10726-110A6	11.21	7.19	0.73	3.78	0.37	0.00	0.49	0.24
liver, adult, pool1	10018-101C9	23.34	7.45	1.78	3.08	0.00	5.19	0.32	0.16
liver, fetal, pool1	10086-102B5	8.47	1.88	0.00	1.88	0.00	2.82	0.94	0.94
locus coeruleus - adult, donor10196	10182-103D2	17.94	14.44	9.33	10.79	10.06	0.29	0.73	1.02
locus coeruleus, adult, donor10252	10165-103B3	25.47	28.42	9.04	26.39	10.89	0.00	0.18	0.74
locus coeruleus, adult, donor10258	10375-105G6	6.77	5.92	4.51	6.77	6.49	0.28	0.28	0.00
locus coeruleus, newborn, donor10223	10362-105F2	18.51	10.09	16.82	12.62	7.99	0.00	0.42	0.42
lung adenocarcinoma cell line:A549	10499-107C4	8.44	4.98	1.80	1.80	0.83	9.27	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	23.44	11.72	0.69	0.69	2.07	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	25.84	11.73	2.11	1.45	0.66	0.00	0.53	0.53
lung, adult, pool1	10019-101D1	22.80	17.13	5.55	5.08	1.18	0.00	0.35	0.00
lung, fetal, donor1	10068-101I5	59.94	51.66	8.28	10.85	11.70	0.00	0.86	0.29
lung, right lower lobe, adult, donor1	10075-102A3	13.75	6.87	5.04	12.83	2.29	0.46	0.92	0.00
lymph node, adult, donor1	10077-102A5	3.31	5.68	0.47	7.57	0.47	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	14.03	5.48	0.00	5.92	0.00	0.00	0.22	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	23.09	7.24	2.41	10.11	3.17	0.00	0.60	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	56.07	16.99	26.33	3.40	5.10	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	31.08	18.65	8.44	4.00	1.78	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	30.51	14.11	8.51	3.11	3.74	0.00	0.00	0.00
mature adipocyte, donor3	12233-129G1	33.66	17.31	7.59	3.08	1.90	0.00	0.24	0.00
mature adipocyte, donor4	12234-129G2	25.27	14.21	11.32	4.47	3.42	0.00	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	31.45	14.30	5.00	7.15	4.29	0.00	0.00	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	23.69	19.18	7.90	9.02	9.02	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	34.57	38.62	12.14	29.06	9.20	0.00	1.84	1.29
medial frontal gyrus, adult, donor10258	10368-105F8	11.12	6.99	7.31	5.72	7.31	0.00	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	15.78	17.06	41.80	4.26	26.44	0.43	2.13	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	15.86	18.39	20.59	10.29	11.14	0.00	4.22	1.01
medial temporal gyrus, adult, donor10252	10156-103A3	29.07	38.62	10.61	35.65	8.49	0.00	1.49	1.70
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	23.12	13.48	1.93	7.71	0.00	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	157.89	100.48	258.37	14.35	86.12	0.00	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	8.97	8.26	12.92	8.97	5.03	0.00	2.15	0.36
medulla oblongata - adult, donor10196	10174-103C3	13.63	12.33	7.14	10.38	3.24	0.00	0.65	1.30
medulla oblongata, adult, donor10252	10155-103A2	31.12	30.81	6.50	28.64	6.50	0.00	0.46	0.77
medulla oblongata, adult, pool1	10038-101F2	26.20	20.41	13.71	9.14	10.61	0.00	0.16	0.41
medulla oblongata, newborn, donor10223	10361-105F1	14.23	16.32	6.94	7.64	6.60	0.00	0.35	0.35
medulloblastoma cell line:D283 Med	10838-111E1	36.53	19.48	13.51	8.64	11.51	0.00	0.89	0.22
medulloblastoma cell line:ONS-76	10759-110E3	9.54	5.99	0.86	1.59	0.37	0.00	0.61	0.00
melanoma cell line:COLO 679	10514-107E1	19.12	6.32	4.31	3.02	2.59	0.00	0.43	0.29
melanoma cell line:G-361	10465-106H6	12.49	7.06	2.44	3.53	1.09	0.00	0.54	0.27
meningioma cell line:HKBMM	10691-109F7	9.05	5.61	0.36	1.45	0.00	0.00	0.00	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	37.01	30.84	7.93	15.86	0.88	0.00	0.88	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	34.22	16.07	16.33	19.96	6.48	0.00	0.26	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	12.12	7.06	3.38	1.53	2.30	0.15	0.31	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	8.18	5.64	1.82	0.91	0.73	0.00	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	7.04	4.56	4.97	2.07	0.41	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	12.22	5.90	1.97	2.11	0.28	0.00	0.28	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	9.24	7.90	1.54	2.31	1.16	0.00	0.39	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	11.80	6.94	5.55	1.39	4.16	0.00	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	8.58	4.12	0.69	1.20	0.34	0.00	0.34	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	12.77	9.55	2.30	1.61	0.81	0.00	0.23	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	10.74	7.96	1.59	3.18	1.19	0.00	0.53	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	12.96	8.24	2.43	2.70	1.49	0.00	0.41	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	13.37	10.53	2.70	3.13	1.56	0.00	0.57	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	12.52	7.90	1.98	2.63	0.66	0.00	0.33	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	15.50	11.07	4.01	2.35	1.25	0.00	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	10.82	6.63	6.98	1.05	1.75	0.00	0.70	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	7.96	9.39	3.67	2.45	1.43	0.00	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	7.91	4.67	3.59	1.44	0.00	0.00	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	8.17	5.79	3.10	1.03	1.14	0.00	0.21	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	10.26	5.70	2.05	0.91	1.14	0.00	1.60	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	13.43	13.43	11.33	3.36	5.87	0.00	1.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	14.35	8.07	3.29	2.39	1.20	0.00	0.60	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	11.55	6.83	2.54	2.45	1.14	0.00	0.35	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	12.52	10.31	0.74	2.21	0.37	0.00	0.00	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	10.59	8.30	5.44	1.43	1.14	0.00	0.86	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	11.37	5.05	9.68	5.47	2.95	0.00	0.00	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	5.02	4.11	1.37	2.74	0.91	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	4.86	5.63	5.12	1.28	0.77	0.00	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	8.90	4.97	3.40	1.05	1.31	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	8.01	4.93	1.54	0.62	0.92	0.00	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	6.83	6.12	6.12	0.94	1.88	0.00	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	9.14	6.43	3.05	1.69	1.02	0.00	0.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	6.68	5.50	2.75	0.79	0.79	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	4.17	6.49	1.85	0.00	0.93	0.00	0.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	10.38	4.04	4.04	1.15	1.44	0.00	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	4.69	4.24	4.69	1.12	1.56	0.00	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	6.01	5.29	2.40	2.40	1.92	0.00	0.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	15.40	11.73	5.13	0.73	1.47	0.00	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	4.36	5.71	2.69	1.01	1.68	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	7.37	2.87	0.41	0.82	1.23	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	3.44	2.15	1.72	1.72	0.00	0.00	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	0.00	13.67	2.73	5.47	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	15.49	10.33	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	4.55	4.55	3.57	1.95	2.60	0.00	0.00	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	1.45	4.36	1.45	1.45	0.00	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	5.33	3.73	3.20	0.53	0.53	0.00	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	4.91	2.45	3.27	0.82	1.64	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	2.33	2.72	1.17	1.55	0.78	0.00	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	2.10	4.20	2.10	0.00	0.00	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	5.96	2.98	4.97	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	4.77	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	6.52	2.96	1.78	2.37	1.19	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	7.31	4.87	1.22	1.22	3.66	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	5.07	2.53	4.43	1.27	0.63	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	4.48	5.17	3.10	1.38	0.69	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	15.04	2.15	0.00	2.15	0.00	0.00	4.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	0.00	3.99	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	10.33	0.00	6.89	0.00	0.00	6.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	5.30	0.81	2.04	0.41	0.00	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	3.18	5.56	0.79	0.79	0.79	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	6.48	0.00	0.59	1.18	0.00	0.00	1.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	3.43	3.43	1.25	1.56	0.31	0.00	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	2.67	6.68	1.34	2.67	0.00	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	4.73	5.91	1.18	2.37	2.37	0.00	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	2.57	0.00	5.14	0.00	2.57	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	13.08	6.88	3.44	1.38	0.69	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	8.91	4.45	3.96	3.46	1.48	0.00	1.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	3.36	7.85	2.24	3.36	0.00	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	8.27	2.54	2.54	1.91	2.54	0.00	1.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	5.24	2.01	0.81	1.21	3.63	0.00	0.81	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	2.18	2.18	2.18	0.00	0.00	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	5.07	1.27	5.07	5.07	2.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	9.10	5.46	3.03	1.82	2.43	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	4.52	0.00	0.00	0.00	0.00	9.04	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	7.41	1.65	4.94	0.82	0.00	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	6.15	1.98	2.78	0.79	1.19	0.00	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	4.22	2.92	1.95	0.32	2.60	0.00	0.97	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	4.07	2.04	4.07	0.00	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	26.31	9.28	5.42	3.09	0.77	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	15.36	7.09	2.36	2.60	0.47	0.00	0.00	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	24.33	12.05	8.11	3.24	2.09	0.23	0.23	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	6.06	1.23	4.42	1.23	2.36	0.51	0.72	0.00
mesothelioma cell line:Mero-25	10850-111F4	5.67	3.18	1.36	1.13	0.91	0.00	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	8.56	7.82	2.20	1.47	0.49	0.00	0.49	0.00
mesothelioma cell line:Mero-48a	10852-111F6	8.64	4.21	2.66	1.55	0.66	0.00	0.44	0.00
mesothelioma cell line:Mero-82	10853-111F7	13.67	2.10	3.42	2.89	0.79	0.00	0.79	0.26
mesothelioma cell line:Mero-83	10854-111F8	11.92	6.30	3.74	4.60	1.87	0.17	0.34	0.34
mesothelioma cell line:Mero-84	10855-111F9	5.81	2.27	1.77	1.77	1.26	1.52	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	10.56	8.28	2.28	2.07	0.21	0.00	0.21	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	7.62	4.14	3.98	1.33	2.82	0.00	0.17	0.00
mesothelioma cell line:NCI-H226	10846-111E9	11.95	4.16	4.34	1.99	3.08	0.00	0.36	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	7.69	3.76	4.27	1.20	0.68	1.54	0.17	0.00
mesothelioma cell line:NCI-H28	10845-111E8	11.45	4.83	1.27	1.53	0.25	3.82	0.00	0.00
mesothelioma cell line:No36	10857-111G2	6.20	3.91	2.28	1.63	2.28	8.48	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	9.21	3.52	2.71	2.17	0.54	0.27	0.27	0.27
migratory langerhans cells, donor1	11901-125F2	7.10	4.80	8.06	4.22	4.99	0.77	0.38	0.19
migratory langerhans cells, donor2	11902-125F3	6.72	5.74	7.08	3.79	6.11	1.59	0.49	0.00
migratory langerhans cells, donor3	11903-125F4	9.69	5.38	5.56	7.18	3.41	0.18	0.18	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	8.49	5.55	0.33	4.24	0.33	0.33	0.65	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	6.36	2.97	0.85	1.27	0.64	0.85	0.21	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	21.42	6.45	1.61	1.84	0.46	0.00	0.23	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	8.37	4.57	4.95	4.00	0.95	0.00	0.00	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	21.44	16.26	4.25	7.21	3.70	0.00	0.18	0.55
myeloma cell line:PCM6	10474-106I6	10.87	3.95	7.51	3.56	0.59	0.00	0.59	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	20.80	9.13	4.06	3.04	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	20.59	5.69	2.35	5.69	0.98	0.00	0.39	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	12.26	5.13	0.33	2.45	0.56	0.00	0.22	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	10.74	3.53	1.18	3.09	0.74	0.00	0.07	0.15
nasal epithelial cells, donor2	12227-129F4	30.36	13.80	3.31	1.66	2.21	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	51.30	18.86	20.48	7.13	2.99	0.00	0.00	1.61
neuroblastoma cell line:NB-1	10539-107G8	23.01	16.46	17.21	8.61	4.68	0.00	0.19	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	31.42	4.43	2.95	6.96	0.63	0.00	0.21	0.63
neuroblastoma cell line:NH-12	10555-107I6	35.78	24.41	10.06	13.04	4.66	0.00	0.75	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	17.32	17.79	3.08	6.17	3.80	0.00	1.42	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	13.15	10.14	8.08	5.54	4.75	0.00	0.32	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	18.11	5.23	6.24	4.03	4.83	0.00	1.21	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	45.78	12.08	9.54	10.17	3.18	0.00	0.64	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	12.78	5.59	2.66	1.86	0.27	0.00	0.27	0.27
neutrophil PMN, donor1	12133-128D9	342.12	119.00	0.00	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	9.47	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	34.33	33.65	14.04	22.15	2.03	0.00	0.68	5.24
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	15.21	8.01	10.41	3.20	3.20	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	9.30	4.81	2.56	2.24	0.64	0.00	0.32	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	8.67	6.04	4.20	1.58	2.63	0.00	0.53	0.53
nucleus accumbens, adult, pool1	10037-101F1	30.00	30.65	18.37	11.53	10.69	0.00	0.66	0.19
occipital cortex - adult, donor10196	10172-103C1	16.48	14.42	14.42	14.42	4.12	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	37.03	39.72	9.12	43.74	6.98	0.00	1.88	1.61
occipital cortex, newborn, donor10223	10355-105E4	16.01	17.11	10.19	6.55	7.64	0.00	1.09	0.36
occipital lobe, adult, donor1	10076-102A4	9.45	11.55	13.12	12.07	4.72	0.00	0.79	0.52
occipital lobe, fetal, donor1	10073-102A1	13.30	20.17	16.31	14.59	6.87	0.00	3.00	0.86
occipital pole, adult, pool1	10036-101E9	18.45	16.48	5.68	4.65	3.63	0.00	0.00	0.32
olfactory region, adult	10195-103E6	14.14	23.31	9.55	10.51	5.16	0.19	1.91	0.96
optic nerve, donor1	10277-104E7	28.01	30.02	12.01	14.01	6.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	26.08	11.28	5.13	3.99	1.37	0.11	0.11	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	22.26	8.38	2.89	4.53	2.34	6.46	0.27	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	40.13	19.81	8.47	4.40	3.73	0.00	2.37	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	14.79	3.47	1.04	2.77	0.35	0.00	0.12	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	11.46	5.29	1.76	1.47	0.29	0.00	0.59	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	66.34	16.82	3.74	0.00	0.00	0.00	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	23.11	11.66	0.21	4.03	0.21	0.00	0.42	1.06
ovary, adult, pool1	10020-101D2	21.49	21.14	3.06	5.77	1.83	0.00	0.35	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	8.62	5.68	0.55	3.85	0.37	0.00	0.92	0.37
pancreas, adult, donor1	10049-101G4	11.29	6.58	10.35	6.58	2.82	0.00	0.94	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	17.61	9.22	0.00	5.03	0.28	0.56	0.00	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	12.27	5.79	2.21	2.90	0.51	0.00	0.51	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	24.34	10.10	5.63	2.98	1.16	1.16	0.66	0.83
paracentral gyrus, adult, pool1	10035-101E8	29.65	24.34	16.11	8.60	12.81	0.00	0.64	0.55
parietal cortex, adult, donor10258	10373-105G4	21.29	17.62	6.61	8.81	3.67	0.00	5.14	0.00
parietal lobe - adult, donor10196	10171-103B9	13.17	20.69	8.46	6.58	5.64	0.00	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	35.91	33.35	13.40	33.35	10.26	0.00	0.86	1.43
parietal lobe, adult, pool1	10034-101E7	29.26	26.17	13.57	10.13	10.05	0.00	0.44	0.62
parietal lobe, fetal, donor1	10072-101I9	27.16	17.46	8.73	13.58	11.64	0.00	0.97	0.97
parietal lobe, newborn, donor10223	10356-105E5	7.48	10.84	14.58	7.10	7.48	0.00	0.75	0.75
parotid gland, adult	10199-103F1	16.65	11.10	18.50	1.85	2.47	0.00	0.00	0.00
penis, adult	10200-103F2	16.65	16.11	5.37	8.06	1.07	0.00	2.15	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	7.25	14.32	3.90	1.86	4.28	0.00	0.37	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	21.27	12.09	6.85	4.95	2.77	0.00	0.58	0.29
pineal gland - adult, donor10196	10179-103C8	25.16	11.61	17.42	8.39	14.19	0.00	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	46.19	34.94	24.28	27.83	50.34	0.00	0.00	1.18
pineal gland, adult, donor10258	10377-105G8	12.54	5.02	8.15	6.27	17.56	0.00	1.25	0.00
pituitary gland - adult, donor10196	10180-103C9	45.53	31.37	48.57	5.06	10.12	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	71.92	39.61	51.60	23.97	29.71	0.52	1.04	0.52
pituitary gland, adult, donor10258	10378-105G9	15.32	11.92	16.17	4.26	8.51	0.00	0.85	0.00
placenta, adult, pool1	10021-101D3	28.27	12.47	4.95	5.38	0.54	0.00	0.11	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	14.96	8.08	1.72	6.62	3.18	0.00	0.66	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	11.98	5.45	0.47	2.02	0.78	0.00	0.16	0.47
pons, adult, pool1	10033-101E6	27.03	20.66	27.46	10.76	22.12	0.00	0.60	0.34
postcentral gyrus, adult, pool1	10032-101E5	26.41	18.83	13.08	7.85	7.76	0.09	0.35	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	248.88	146.40	2.09	39.74	0.00	0.00	0.00	14.64
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	11.02	5.51	0.00	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	11.74	11.74	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	8.74	5.83	3.79	1.31	2.48	0.73	0.58	0.29
prostate cancer cell line:PC-3	10439-106E7	37.03	17.79	4.54	5.99	3.99	0.00	0.73	0.54
prostate, adult, pool1	10022-101D4	19.95	18.86	3.45	6.08	1.63	0.00	0.27	0.18
putamen, adult, donor10196	10176-103C5	31.40	51.93	18.89	18.65	9.91	0.00	0.94	0.94
putamen, adult, donor10252	10152-102I8	11.76	15.69	5.88	9.80	1.96	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	17.48	20.76	2.19	1.09	2.19	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	16.43	24.89	3.87	6.04	3.14	0.00	0.72	0.48
putamen, newborn, donor10223	10365-105F5	11.24	5.25	19.49	12.74	13.49	0.00	1.50	0.75
rectal cancer cell line:TT1TKB	10469-106I1	28.22	10.76	0.00	2.33	0.00	2.04	0.29	1.16
rectum, fetal, donor1	10067-101I4	16.69	23.65	6.95	12.52	2.78	1.39	0.00	4.17
renal cell carcinoma cell line:OS-RC-2	10411-106B6	4.45	6.36	3.82	1.06	2.76	0.21	0.85	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	9.53	9.94	7.04	5.38	1.24	7.04	0.41	0.83
retina, adult, pool1	10030-101E3	28.53	21.37	13.62	6.86	15.90	0.00	0.70	0.10
retinoblastoma cell line:Y79	10475-106I7	37.41	22.60	3.12	9.09	3.38	0.00	1.56	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	19.18	15.12	3.57	7.13	2.21	0.00	0.37	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	44.43	16.03	10.69	5.34	6.47	0.00	0.00	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	37.13	16.67	0.76	3.03	1.52	0.00	0.76	0.76
salivary acinar cells, donor1	11771-123I7	23.63	8.90	3.08	1.29	1.29	0.00	0.32	0.32
salivary acinar cells, donor2	11772-123I8	19.28	8.54	3.03	2.20	1.65	0.00	0.28	0.41
salivary acinar cells, donor3	11773-123I9	70.84	23.17	1.32	3.31	0.00	0.00	0.00	1.99
salivary gland, adult, pool1	10093-102C3	40.04	16.01	14.30	0.57	2.29	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	4.38	4.13	1.43	1.52	1.18	0.00	0.17	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	2.47	2.70	1.88	1.29	0.94	0.00	0.12	0.00
seminal vesicle, adult	10201-103F3	31.74	29.63	7.41	5.29	3.17	0.53	0.53	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	26.24	11.17	5.34	4.13	2.92	0.00	0.97	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	12.83	2.01	1.26	1.26	0.75	0.00	0.75	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	16.06	4.01	4.01	1.00	0.00	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	11.95	6.72	2.28	5.51	1.07	0.00	0.67	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	27.08	7.29	2.76	1.44	1.22	0.33	0.11	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	23.61	4.52	3.23	1.55	1.94	15.48	0.13	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	24.83	27.66	14.90	6.38	2.13	0.00	0.00	1.42
skeletal muscle, adult, pool1	10023-101D5	25.19	12.71	7.08	3.96	2.16	0.00	0.24	0.96
skeletal muscle, fetal, donor1	10066-101I3	4.02	10.05	4.02	2.01	2.01	0.00	2.01	0.00
skin, adult, donor1	10074-102A2	13.57	6.79	6.79	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	22.09	18.94	5.05	6.94	0.63	0.00	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	20.01	12.01	3.34	6.34	1.00	0.00	0.33	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	43.18	15.45	7.88	9.77	4.41	0.00	0.63	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	12.91	16.19	0.19	6.55	0.39	0.00	0.39	1.16
small cell lung carcinoma cell line:LK-2	10541-107H1	32.80	7.09	2.80	4.12	1.15	0.16	0.16	0.99
small cell lung carcinoma cell line:NCI-H82	10842-111E5	19.46	21.71	1.77	6.27	6.43	0.16	0.16	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	23.97	4.58	7.85	5.67	2.40	0.00	0.22	0.44
small intestine, adult, pool1	10024-101D6	40.01	13.86	7.88	5.85	1.91	2.75	0.24	0.24
small intestine, fetal, donor1	10064-101I1	12.04	7.62	4.91	3.19	2.21	1.23	0.49	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	19.49	6.15	7.18	3.59	6.15	0.00	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	18.09	16.80	5.43	5.43	1.03	0.00	1.55	0.26
somatostatinoma cell line:QGP-1	10781-110G7	30.02	6.43	8.04	3.48	3.75	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	11.93	12.16	8.95	11.93	5.51	0.00	0.92	1.38
spinal cord, adult, donor10252	10159-103A6	18.14	27.99	5.13	20.11	5.52	0.00	0.39	0.39
spinal cord, adult, donor10258	10369-105F9	9.69	2.77	4.84	11.07	6.23	0.69	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	16.47	11.59	8.54	14.03	9.15	0.00	2.44	0.61
spinal cord, newborn, donor10223	10359-105E8	12.40	11.48	13.32	17.91	11.94	0.00	1.84	2.76
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	13.14	6.27	3.14	1.64	0.75	0.00	0.30	0.00
spleen, adult, pool1	10025-101D7	17.95	14.43	4.52	7.82	0.66	0.00	0.66	0.22
spleen, fetal, pool1	10044-101F8	18.99	19.63	4.37	9.14	0.72	0.08	0.32	0.79
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	12.52	6.11	4.45	8.59	3.21	0.00	0.10	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	23.92	9.87	10.63	2.66	1.71	0.00	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	17.47	11.88	1.75	4.89	2.10	0.00	2.45	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	21.89	7.04	5.47	1.17	0.78	0.00	1.56	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	24.65	9.57	13.51	2.03	4.84	0.00	0.68	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	6.78	4.24	0.00	2.97	0.00	1.69	0.85	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	14.81	6.77	0.85	1.69	0.00	0.00	0.85	0.85
stomach, fetal, donor1	10062-101H8	38.45	34.18	5.34	6.41	2.14	0.00	0.00	3.20
submaxillary gland, adult	10202-103F4	35.89	18.23	11.39	3.99	2.85	0.57	1.14	1.14
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	22.85	28.46	3.74	27.42	4.78	0.00	2.08	1.04
substantia nigra, adult, donor10258	10371-105G2	17.07	9.83	5.69	8.28	6.21	0.00	2.07	0.52
substantia nigra, newborn, donor10223	10358-105E7	7.77	4.95	7.77	14.13	9.19	0.00	0.71	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	19.95	15.13	3.90	6.65	2.52	0.00	0.69	1.83
temporal lobe, adult, pool1	10031-101E4	13.90	19.92	8.31	6.10	4.66	0.00	0.25	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	19.94	26.35	13.53	11.40	9.26	0.00	0.71	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	31.21	32.97	13.63	7.91	5.71	0.00	1.76	0.00
tenocyte, donor1	11763-123H8	7.68	7.33	3.49	2.09	1.40	0.00	0.70	0.35
tenocyte, donor2	11765-123I1	5.34	2.29	0.76	0.38	0.38	0.00	0.76	0.00
tenocyte, donor3	11768-123I4	5.56	5.56	3.34	1.48	1.11	0.00	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	19.38	12.07	9.35	9.35	5.27	8.16	1.36	0.68
teratocarcinoma cell line:NCR-G1	10798-110I6	13.57	6.32	0.46	8.17	0.46	0.00	1.08	0.15
teratocarcinoma cell line:PA-1	10807-111A6	17.36	7.90	2.32	4.03	2.79	0.00	0.15	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	14.85	14.98	0.51	9.27	0.38	16.00	0.13	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	7.56	14.75	0.00	6.05	0.38	1.51	0.76	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	32.17	24.10	0.11	4.58	0.44	1.53	0.65	0.76
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	9.45	21.17	0.00	2.93	0.00	0.00	0.98	0.65
testis, adult, pool1	10026-101D8	12.78	15.03	6.98	10.20	2.25	0.11	1.07	0.21
testis, adult, pool2	10096-102C6	10.37	12.63	4.51	10.37	2.71	0.00	0.00	0.45
thalamus - adult, donor10196	10168-103B6	20.98	12.14	9.94	12.14	7.73	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	25.63	37.04	7.66	27.51	7.03	0.00	1.56	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	18.48	9.24	18.48	0.00	9.24	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	4.12	3.46	4.94	6.42	3.79	0.00	0.66	0.16
thalamus, newborn, donor10223	10366-105F6	6.90	2.30	17.83	12.08	12.66	0.00	1.73	0.58
throat, adult	10209-103G2	23.22	22.22	5.99	5.24	1.75	0.00	0.50	0.25
throat, fetal, donor1	10061-101H7	16.15	13.71	4.57	6.70	2.13	0.00	0.61	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	29.01	31.00	0.20	7.15	0.20	0.00	0.99	0.79
thymus, adult, pool1	10027-101D9	32.41	18.39	4.47	16.80	2.29	0.00	0.89	1.29
thymus, fetal, pool1	10043-101F7	55.90	39.48	6.34	22.76	2.39	0.10	0.42	1.66
thyroid carcinoma cell line:KHM-5M	10776-110G2	6.91	4.52	3.19	3.06	1.33	0.00	0.40	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	9.78	4.75	1.40	2.37	1.82	0.14	0.42	0.28
thyroid, adult, pool1	10028-101E1	22.02	15.58	2.24	6.25	1.03	0.00	0.47	0.28
thyroid, fetal, donor1	10060-101H6	17.40	12.39	5.80	5.80	1.32	0.00	0.26	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	49.27	30.80	3.08	6.16	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	21.40	13.49	5.12	3.72	0.93	0.00	0.93	0.23
tongue, fetal, donor1	10059-101H5	11.82	7.49	11.03	3.94	2.36	0.00	0.79	0.00
tonsil, adult, pool1	10047-101G2	29.55	19.33	3.71	10.82	1.80	0.00	0.40	0.50
trachea, adult, pool1	10029-101E2	26.67	14.72	5.56	4.01	2.78	0.08	0.16	0.16
trachea, fetal, donor1	10058-101H4	16.54	15.39	3.85	3.08	3.08	0.00	0.77	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	8.50	6.02	4.25	2.48	1.06	0.00	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	17.93	6.28	2.43	4.26	0.81	0.00	0.10	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	19.59	14.26	7.21	3.76	1.88	0.00	0.78	0.16
tridermal teratoma cell line:HGRT	10694-109G1	47.56	17.12	7.61	5.71	3.81	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	12.95	8.13	4.74	1.27	1.52	0.00	0.42	0.25
umbilical cord, fetal, donor1	10057-101H3	14.61	8.35	4.17	4.17	0.00	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	27.81	35.15	5.97	5.80	2.90	0.00	0.34	0.85
uterus, fetal, donor1	10055-101H1	10.24	14.33	4.10	5.63	3.07	0.00	0.51	0.00
vagina, adult	10204-103F6	12.92	17.45	3.23	18.09	0.65	0.00	0.00	0.00
vein, adult	10191-103E2	19.51	16.22	3.29	9.64	0.44	0.00	0.44	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	12.28	4.54	0.00	6.68	0.00	0.00	0.80	0.00

Property "Nearest transcripts" (as page type) with input value "BC043394:-161 BC004173:-173 ENST00000639793.1:-179 LF383978:-179 MA619555:-179 AF308285:-179 ENST00000358602.9:-192 ENST00000330838.10:-192 ENST00000561029.1:-192 NM_032217.5:-192 NM_015574.2:-192 NM_198889.3:-192 AK307581:-192 LF358950:222 MA594527:222 ENST00000558247.5:254 AB014597:254" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.